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ABSTRACT OF DISSERTATION 
 
 
 
 
 
ALTERATIONS IN GABAERGIC NTS NEURON FUNCTION IN ASSOCIATION 
WITH TLE AND SUDEP 
 
Epilepsy is a neurological disorder that is characterized by aberrant electrical 
activity in the brain resulting in at least two unprovoked seizures over a period 
longer than 24 hours. Approximately 60% of individuals with epilepsy are 
diagnosed with temporal lobe epilepsy (TLE) and about one third of those 
individuals do not respond well to anti-seizure medications. This places those 
individuals at high risk for sudden unexpected death in epilepsy (SUDEP). SUDEP 
is defined as when an individual with epilepsy, who is otherwise healthy, dies 
suddenly and unexpectedly for unknown reasons. SUDEP is one of the leading 
causes of death in individuals with acquired epilepsies (i.e. not due to genetic 
mutations), such as TLE. Previous studies utilizing genetic models of epilepsy 
have suggested that circuitry within the vagal complex of the brainstem may play 
a role in SUDEP risk. Gamma-aminobutyric acid (GABA) neurons of the nucleus 
tractus solitarius (NTS) within the vagal complex receive, filter, and modulate 
cardiorespiratory information from the vagus nerve. GABAergic NTS neurons then 
project to cardiac vagal motor neurons, eventually effecting parasympathetic 
output to the periphery. In this study, a mouse model of TLE was used to assess 
the effect of epileptogenesis on GABAergic NTS neuron function and determine if 
functional alterations in these neurons impact SUDEP risk. It was discovered that 
mice with TLE (i.e. TLE mice) have significantly increased mortality rates 
compared to control animals, suggesting that SUDEP occurs in this model. Using 
whole cell electrophysiology synaptic and intrinsic properties of GABAergic NTS 
neurons were investigated in TLE and control mice. Results suggest that during 
epileptogenesis, GABAergic NTS neurons become hyperexcitable, potentially due 
to a reduction in A-type potassium channel current and increased excitatory 
synaptic input. Increases in hyperexcitability have been shown to be associated 
with an increased risk of spreading depolarization and action potential inactivation 
leading to neuronal quiescence. This may lead to a decreased inhibition of 
parasympathetic tone, causing cardiorespiratory collapse and SUDEP in TLE.  
 
KEYWORDS: temporal lobe epilepsy, sudden unexpected death in epilepsy, NTS, 
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Chapter 1 Introduction 
1.1 Sudden unexpected death in epilepsy 
1.1.1 History and Definitions 
The International League Against Epilepsy defines epilepsy as when an 
individual has at least two unprovoked seizures occurring greater than 24 hours 
apart (Fisher et al., 2014). It has been well-established that death in individuals 
with epilepsy can be attributed to the epilepsy itself or to a seizure that is unable 
to stopped by medication (Mackenzie Bacon, 1868; Spratling, 1902; Munson, 
1910; Hauser et al., 1980; Nashef and Brown, 1996; Nashef and Sander, 1996). 
According to the Centers for Disease Control, about 1.2% of the United States 
population have epilepsy, which amounts to about 3.4 million individuals 
nationwide. Individuals with epilepsy have a 2.5-fold increase in the risk for sudden 
death compared to a healthy individual (Shackleton et al., 1999). One of the 
leading causes of death in individuals with epilepsy is sudden unexpected death 
in epilepsy (SUDEP) (Nashef, 1997; Nashef et al., 1998; Kloster and Engelskjon, 
1999; Lhatoo and Sander, 2005; Tomson et al., 2008; Tolstykh and Cavazos, 
2013; Ellis and Szabo, 2018). Case studies of SUDEP first appear in the literature 
in the early 1970’s via investigation of death certificates of individuals with epilepsy  
(Hirsch and Martin, 1971). Up until the use of translational animal models of 
epilepsy, SUDEP research focused on postmortem investigations and single-
patient case studies (Terrence et al., 1975; Sarkioja and Hirvonen, 1984; Leestma 
et al., 1989; Dasheiff, 1991). By the mid-1990’s SUDEP research experienced a 
resurgence, and several definitions of SUDEP were developed.  
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The definition of SUDEP, first published in 1997, is: “sudden, unexpected, 
unwitnessed or witnessed, non-traumatic and non-drowning death in patients with 
epilepsy, with or without status epilepticus, in which postmortem examination does 
not reveal a toxicologic or anatomic cause for death” (Nashef, 1997). More 
recently, the definition has been slightly modified to include that the death was not 
directly caused by a seizure (Annegers, 1997; Annegers and Coan, 1999). SUDEP 
cases are also divided into four categories: definite, probable, possible, and 
unlikely SUDEP (Annegers, 1997). Definite SUDEP meets all the definition criteria 
and has a description of the circumstances of death. Probable SUDEP meets the 
criteria but does not have postmortem information. Possible SUDEP includes 
cases where SUDEP cannot be ruled out, but also cannot be sufficiently confirmed 
based on medical records. Unlikely SUDEP includes deaths for which other causes 
are clearly established or circumstances make SUDEP improbable (Annegers, 
1997). It can be difficult to ascertain if individuals with epilepsy have died from 
SUDEP because most individuals are not continuously monitored in the home 
setting. Presently, it is difficult to accurately identify individuals at risk for SUDEP 
and research has yet to identify underlying biomarkers for and mechanisms of 
SUDEP.  
1.1.2 Patient Characteristics 
The incidence of SUDEP in the United States is about 1.2 out of every 1000 
individuals with epilepsy (Harden et al., 2017). Early studies examining individuals 
with epilepsy focused on potential cardiac and respiratory abnormalities. 
Individuals with epilepsy that are not previously diagnosed with a cardiac pathology 
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have an increased heart rate and electrocardiographic (ECG) abnormalities (e.g. 
QT lengthening) (Drake et al., 1993). Individuals with epilepsy were also shown to 
have apnea during a generalized tonic-clonic seizure (GTCS) (Fish, 1997). As 
early as 1987, it was hypothesized that autonomic nervous system imbalance, 
cardiac arrhythmia, and epilepsy may be linked (Lathers et al., 1987). 
There have been many studies assessing potential risk factors for SUDEP 
in individuals with epilepsy. The risk for SUDEP has been well-established to 
increase with the duration of epilepsy, seizure severity, and seizure frequency 
(Ficker et al., 1998; Sperling, 2001; Devinsky, 2011), potentially because these 
individuals have a longer history of seizure events. It has been shown that the 
frequency of GTCS is strongly associated with SUDEP risk, regardless of the 
number of medications the individual has previously been prescribed (Lamberts et 
al., 2012). Therefore, it is crucial to decrease seizure frequency in order to 
attenuate SUDEP risk. However, not all individuals with epilepsy have seizures 
that are well-controlled with the first medication they are prescribed. Often, 
treatment with two or three medications is necessary before seizure frequency 
decreases. Even so, about 30% of individuals are unable to resolve their seizures 
by medication or surgery and have refractory epilepsy. This patient population is 
one of the highest at risk for SUDEP (Devinsky, 2011; Tolstykh and Cavazos, 
2013; Thurman et al., 2014). Another patient risk factor is compliance with anti-
epileptic medications (AEMs). It has been shown that if an individual with epilepsy 
does not follow their treatment regimen, their risk for seizures increases, thus 
increasing the risk for SUDEP. The environment in which a patient sleeps may also 
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play a role in increasing the likelihood of SUDEP. Patient studies have shown that 
individuals who have suffered from SUDEP, tend to have a lack of nighttime 
supervision and tend to be found in the prone position (Devinsky, 2011).  
 Autonomic imbalance relating to cardiorespiratory function in epilepsy 
patients may also be a risk factor for SUDEP. A study examining data from epilepsy 
monitoring units (EMUs) world-wide found that many individuals that suffered from 
SUDEP experienced respiratory abnormalities such as apnea (Ryvlin et al., 2013). 
During a seizure event, individuals with epilepsy have displayed cardiac 
arrhythmias, postictal bradycardia, and asystole (Surges and Sander, 2012). 
Additionally, some individuals have displayed lengthy postictal EEG suppression 
(PGES), characterized by a flat-lining of the electroencephalogram (EEG) after a 
seizure event. These individuals have a higher risk for SUDEP compared to those 
with shorter PGES (Lhatoo et al., 2010a; Surges et al., 2010). However, specific 
mechanisms that elucidate these risk factors or identify biomarkers for SUDEP 
remain to be established. 
1.2 Suggested Mechanisms of SUDEP 
In the past 5-10 years there has been an increased amount of research 
focused on potential mechanisms of SUDEP. Many of these studies utilize 
genetic mouse models of SUDEP, which will be further detailed in a following 
section. Dlouhy et al. hypothesized that a generalized tonic-clonic seizure 
(GTCS) spreads to three areas eventually resulting in SUDEP: the midbrain, 
respiratory centers and brainstem cardiovascular centers (Dlouhy et al., 2016). 
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1.2.1 The Midbrain 
The midbrain is a portion of the central nervous system that is associated 
with vision, hearing, motor control, wakefulness, arousal, and temperature 
regulation. It contains the following structures: tectum, tegmentum, cerebral 
aqueduct, and peduncles. It adjoins to the pons, cerebellum, thalamus, and 
hypothalamus. Upon spread to the midbrain, seizures inhibit the ascending arousal 
system, located in the brainstem, which plays a role in sleep-wake consciousness 
(Dlouhy et al., 2016). Individuals with epilepsy that have suffered from SUDEP are 
often found lying in the prone position and researchers have hypothesized that this 
is due to dysfunction within the arousal system (Langan et al., 2000; Ryvlin et al., 
2013; Sowers et al., 2013; Ellis and Szabo, 2018). The ascending arousal system, 
or ascending reticular activating system (ARAS), originates in the upper brainstem 
and is involved in regulating sleep-wake transitions via its interaction with the 
ventrolateral preoptic nucleus (VLPO). The primary neurotransmitter in the VLPO, 
γ-aminobutyric acid (GABA) inhibits ARAS during sleep. Interactions between the 
VLPO and ARAS maintains a sleep-wake switch (Edlow et al., 2012). In individuals 
with epilepsy this switch may malfunction, which could be an underlying factor in 
the correlation between nighttime seizures, inability to wake up at that time, and 
SUDEP (Lamberts et al., 2012; Sowers et al., 2013; Gumusyayla et al., 2016). 
Additionally, patients with epilepsy show dysfunction in the ARAS when measured 
via polysomnography and magnetic resonance imaging (MRI) (Gumusyayla et al., 
2016; Englot et al., 2017b). Dysfunction within the arousal system does put 
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individuals with epilepsy at a higher risk for SUDEP but the neuronal mechanisms 
that contribute to this dysfunction remain to be elucidated.  
1.2.2 Postictal EEG Suppression 
PGES is defined as the absence of EEG activity (i.e. less than 10 µV in 
amplitude allowing for muscle movement, breathing, and electrode artifacts) 
(Lhatoo et al., 2010a). PGES is characterized by a short collapse of cardiac and 
respiratory rates post-seizure. There have been several studies examining patient 
incidence of PGES in association with seizures and SUDEP. An early study did a 
post-hoc examination of video EEG of individuals with epilepsy, some of whom 
went on to die of SUDEP (Lhatoo et al., 2010a). Fifty percent of patients had PGES 
following a seizure and its duration was significantly longer in the individuals that 
eventually died of SUDEP (Lhatoo et al., 2010a). Another study examined the 
association between PGES, seizure type, and SUDEP. While they found that 
PGES occurred postictally, neither the presence nor duration of PGES was 
significantly associated with SUDEP as an independent risk factor (Surges et al., 
2011). Another study concluded that PGES is not related to seizure duration or 
severity, but that it is related to oxygen desaturation during a seizure (Seyal et al., 
2012). Lee et al. did a retrospective analysis of heart rate and PGES in individuals 
with nocturnal seizures and also found that PGES did not impact SUDEP risk (Lee 
et al., 2013). Similarly, Lamberts et al., found that PGES was not significantly 
correlated with autonomic instability but did find an association with nocturnal 
seizures (Lamberts et al., 2013). Kuo et al., monitored patients with GTCS for 
PGES and found that it was not associated with seizure phase or duration (Kuo et 
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al., 2016). However, another study found that PGES duration was increased when 
seizure onset occurred during sleep (Peng et al., 2017). Contradictory to the 
previously mentioned studies, it was recently found that individuals that died of 
SUDEP had a shorter, not longer, PGES duration in association with SUDEP risk 
(Kang et al., 2017). Overall, the evidence regarding whether PGES is related to 
SUDEP remains inconclusive. However, alterations in both the arousal system and 
PGES in SUDEP have led researchers to postulate that the serotonergic system 
(5-HT), in addition to the respiratory centers may play a role. 
1.2.3 Respiratory Centers 
Recently respiratory dysfunction has been more closely examined as a 
potential mechanism for SUDEP because hypoxia, apnea, and other respiratory-
related dysfunction have been shown to occur during seizures. (Watanabe et al., 
1982; Coulter, 1984; James et al., 1991). Recently, respiratory dysfunction has 
been more closely examined as a potential mechanism for SUDEP. Nelson and 
Ray in 1968 published one of the first accounts of respiratory arrest after seizure 
but it was not until 1999 that parameters were published to monitor these changes 
in individuals with epilepsy (Fish, 1997). Apnea (i.e. temporary cessation of 
breathing) occurs in 100% of generalized seizures and since it is associated with 
hypoxia, researchers concluded that respiratory function should be monitored in 
epilepsy patients (Fish, 1997). In 1996, Nashef et al. showed that greater than 50% 
of patients had apnea in concert with seizures (Nashef et al., 1996). Additionally, 
these respiratory parameters are associated with impaired ventilation, O2 
desaturation, and hypoxia (Blum et al., 2000; Sowers et al., 2013). O2 saturation 
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has been shown to drop to below 90% in some individuals and the longer a seizure 
lasts, the lower saturation becomes. In what is thought to be a seminal study by 
Ryvlin et al., respiratory and cardiac data from international EMUs was examined 
in cases where individuals died of SUDEP (Ryvlin et al., 2013). One of their major 
conclusions was that SUDEP was preceded by terminal apnea, followed by cardiac 
arrest and death (Ryvlin et al., 2013). This study is problematic for several reasons, 
one of which being that all respiratory measurements were done by visual 
inspection of EMU patient videos. No quantitative measurements were taken and 
no mention is made regarding the quality of the video or how visible the lack of 
respiratory movement was. Additionally, there was no effort made to resuscitate 5 
out of the 16 patients that died of SUDEP. It was also not stated if individuals in 
this study had been previously diagnosed with any pulmonary dysfunction, which 
may have played a role in SUDEP.  
 Stimulation of higher brainstem centers to elicit seizures has been shown 
to be associated with respiratory depression. Stimulation in the orbital frontal 
cortex, temporal lobe, and amygdala can result in respiratory depression and 
central apnea (Kaada and Jasper, 1952; Bonvallet and Bobo, 1972). More 
recently, high resolution brain mapping has shown that seizures originating in the 
frontotemporal region, spread to the amygdala, eliciting central apnea (Dlouhy et 
al., 2015). Interestingly, during these procedures individuals were awake, but not 
aware that the apnea occurred. These data suggest that seizures may spread to 
and affect brain regions that are crucial for basic functions. There are other higher 
brain pathways that project downstream; for example, the temporal lobe connects 
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to respiratory centers (Bateman et al., 2010a; Faingold et al., 2010; Faingold, 
2012). While these areas and the spread of seizures to respiratory nuclei may be 
involved in SUDEP, the neurons in these brain regions have yet to be directly 
examined in this context. In examining respiratory function and SUDEP, there are 
few studies that make direct measurements of breathing, so this potential 
mechanism remains poorly understood. One of the things that PGES and 
respiratory function have in common is signaling through serotonergic/5-
hydroxytryptamine (5-HT) neurons (Ellis and Szabo, 2018).  
1.2.4 5-HT Neurons 
5-HT is a monoamine neurotransmitter that is primarily found within the 
raphe nuclei of the brainstem (Jacobs and Azmitia, 1992; Sowers et al., 2013). 5-
HT neurons receive connections from a wide variety of regions, including the 
cortex, hypothalamus, and brainstem, and projects to many regions within the 
central nervous system (Sowers et al., 2013). 5-HT is involved in many brain 
functions, such as respiration, arousal, anxiety, depression, and central 
chemoreception (Sowers et al., 2013; Kennedy and Seyal, 2015). Since 5-HT 
neurons stimulate respiration and arousal, dysfunction in this system has been 
hypothesized to sudden death (Richerson and Buchanan, 2011).  
 The Pre-Bötzinger complex (BPC) in the brainstem is responsible for 
breathing, hypoxia, and gasping responses. The proper function of the BPC is 
dependent on 5-HT receptor activation by serotonin (Richerson, 2004; Hodges and 
Richerson, 2010; Massey et al., 2014). In mice where 5-HT receptors are deleted, 
they have apnea, increased mortality, and defects in arousal (Hodges et al., 2008; 
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Hodges et al., 2009; Buchanan et al., 2014). A separate study examined neuronal 
inhibition of 5-HT neurons with Designer Receptors Exclusively Activated by 
Designer Drugs (DREADDs) and found that ventilation was significantly blunted 
(Ray et al., 2011). Medullary 5-HT neurons act as chemoreceptors and respond to 
small changes in physiologic pH (Wang et al., 1998; Wang et al., 2001c; Richerson 
et al., 2005; Corcoran et al., 2009). Increased firing of 5-HT neurons increases 
respiratory output (Ptak et al., 2009). 5-HT neurons in the midbrain act as 
chemoreceptors by inducing arousal in response to changes in arterial carbon 
dioxide, which has been hypothesized to be defective in SUDEP. It is postulated 
that after a seizure, the individual would be unresponsive as the pillow blocks the 
airway and being unable to relieve the obstruction would result in hypoxia and 
death (Sowers et al., 2013). Earlier work with animals that lack the 5-HT2C receptor, 
provides evidence of serotonin’s involvement with SUDEP, as these mice suffer 
from respiratory depression and mortality (Brennan et al., 1997). In the DBA/2 
mouse, administration of a selective serotonin reuptake inhibitor (SSRI) reduces 
respiratory depression and mortality (Tupal and Faingold, 2006). These mice also 
have abnormal 5-HT receptor expression in the brainstem (Uteshev et al., 2010). 
In some individuals with epilepsy, SSRIs reduced the incidence of seizure-induced 
apnea (Bateman et al., 2010b; Dlouhy et al., 2016). The SSRI fluoxetine has also 
been shown to prevent respiratory arrest in the DBA/2 and DBA/1 mouse models 
(Faingold et al., 2011b; Faingold et al., 2011a). There are several AEMs that also 
increase 5-HT extracellular concentrations as a by-product of their function (Bagdy 
et al., 2007). Previous studies have also shown that there is a decrease in 5-HT1A 
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receptor binding in individuals with epilepsy (Toczek et al., 2003; Savic et al., 2004; 
Richerson and Buchanan, 2011). However, there is no evidence of 5-HT gene 
mutations in patients that are directly linked to epilepsy (Richerson and Buchanan, 
2011). In 2016, Zhan et al. showed a decrease in 5-HT neuronal firing in the 
medullary raphe after an electrically induced seizure (Zhan et al., 2016). While this 
study was able to show a direct link between a single seizure and 5-HT function, 
individuals at risk for SUDEP have a history of seizures. This study does not 
address the potential effect multiple seizures, over a period of time, has on 5-HT 
function and subsequent respiratory output. Another study examined postictal 
serotonin levels in individuals with epilepsy. They found that serum serotonin was 
significantly increased post-GTCS compared to interictal levels, suggesting that 5-
HT is acutely altered post-seizure. While it appears that 5-HT is generally involved 
in epilepsy, it is does not conclusively cause of SUDEP. Further work needs to be 
done in brainstem regions to provide direct evidence of 5-HT and SUDEP. 
1.2.5 Cardiac and Autonomic Dysfunction  
Another focus of potential SUDEP mechanisms are cardiac and autonomic 
changes in relation to epilepsy that may contribute to sudden death. Peri-ictal 
autonomic dysregulation in individuals with epilepsy has been published as early 
as 1972 by Gastaut (Gastaut, 1972). The autonomic nervous system is responsible 
for regulating sympathetic and parasympathetic output to the periphery, including 
partially modulating cardiac activity. Information regarding cardiac function and 
blood pressure is relayed to the brainstem via the afferent fibers of the vagus 
nerve. Blood pressure changes are influenced primarily by the baroreceptor reflex, 
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which involves baroreceptors located on the carotid sinus and aortic arch. The 
baroreceptors travel up the afferent fibers of the vagus nerve, directly to neurons 
within the brainstem, in a region called the nucleus tractus solitarius (NTS). 
Excitatory NTS neurons synapse to the caudal ventrolateral medulla (CVLM), 
which projects to the rostral ventrolateral medulla (RVLM), inhibiting those 
neurons. As the primary regulator of sympathetic output to the periphery, the 
RVLM projects glutamatergic fibers to sympathetic preganglionic neurons in the 
spinal cord. When blood pressure increases, the baroreceptors are activated and 
the NTS increases excitatory neurotransmission to the CVLM, inhibiting the RVLM, 
decreasing excitatory neurotransmission to the heart and decreasing blood 
pressure. When blood pressure is low, the baroreceptors receive less tonic 
activation and the sympathetic output increases to maintain a steady blood 
pressure. GABAergic NTS neurons synapse to cardiac vagal motor neurons 
(CVMNs) in the nucleus ambiguus (NA) and the dorsal motor nucleus of the vagus 
(DMV) to regulate vagal tone, slowing heart rate. This is further increased when 
blood pressure is high. It is important to note that the circuitry relating to the 
parasympathetic nervous system is primarily directed toward regulating heart rate 
(Gordan et al., 2015). 
 With regard to cardiac function, the sympathetic nervous system serves to 
increase heart rate and myocardial contractility under various pathological 
conditions. The parasympathetic nervous system serves to reduce heart rate and 
functions primarily during sleep or resting conditions. An additional factor in heart 
rate that is influenced by the autonomic nervous system is heart rate variability 
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(HRV), which is defined as the variation in the time between each heartbeat. 
Clinically, two measures of HRV are the standard deviation between the R-R 
intervals (SDNN) and the root mean squared of the R-R interval (RMSSD) (Stein 
and Kleiger, 1999). The SDNN is interpreted as the general HRV and the RMSSD 
as the parasympathetic or vagal tone component of HRV (Shaffer and Ginsberg, 
2017).  Studies examining individuals with epilepsy in association with cardiac 
function have focused primarily on changes in blood pressure, heart rhythms, and 
HRV as potential mechanisms of SUDEP. There have  been a paucity of studies 
investigating blood pressure changes as a potential mechanism for SUDEP. The 
first paper was a patient case study which examined an individual with epilepsy 
and measured systolic, diastolic, and mean arterial blood pressure. In this case, a 
GTCS during sleep increased blood pressure measurements, and the patient 
showed a period of post-ictal hypotension that concluded with PGES (Bozorgi et 
al., 2013). Since this patient had no prior history of cardiac dysfunction, this study 
suggests that the seizure had an impact on autonomic control of blood pressure. 
It would have been more impactful to measure interictal blood pressure to see if it 
is altered without a seizure event as a measure of autonomic dysfunction. Another 
study compared awake interictal blood pressure and heart rate in individuals that 
eventually died of SUDEP to refractory and AEM controlled individuals (Nei et al., 
2016). Their retrospective analysis showed that there was a trend towards an 
increase in diastolic blood pressure in individuals who eventually died of SUDEP 
(Nei et al., 2016). However, the authors only used heart rate and blood pressure 
measurements from the three most recent outpatient visits and available peri-
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mortem data was not reported. Another study measured mean arterial blood 
pressure, heart rate, and O2 saturation in individuals with focal and bilateral 
seizures (Hampel et al., 2016). This study found no changes in O2 saturation but 
mean arterial blood pressure was increased (Hampel et al 2016). However, they 
did not state if this change was post-seizure, and therefore cannot make 
conclusions regarding autonomic changes related to seizure activity.  Conflictingly, 
another study by the same group found that there were no alterations in the 
baroreflex response in individuals with focal seizures (Hampel et al., 2017). While 
the data suggest that blood pressure and baroreflex sensitivity is altered in 
individuals with epilepsy, it has not been shown that these changes cause SUDEP. 
More work needs to be done where blood pressure and the baroreflex response 
are consistently monitored in individuals with epilepsy over time.  
 Epilepsy researchers have also hypothesized that autonomic dysfunction 
manifesting itself as a change in HRV, arrhythmia, tachycardia, asystole, 
bradycardia, and QT lengthening, occurring pre-ictally, ictally, post-ictally, and 
peri-ictally contribute to SUDEP (Stollberger and Finsterer, 2004; Massey et al., 
2014; Bermeo-Ovalle et al., 2015). However, in many of these patients, information 
regarding prior cardiovascular disease diagnoses or medications is often lacking, 
making it difficult to account for confounding variables.  
Several forebrain structures including the hippocampus, medial frontal 
cortex, and hypothalamus are involved in seizure networks and autonomic output  
(Cechetto and Chen, 1990). These areas project to the brainstem, regulating 
sympathetic and parasympathetic function. HRV is primarily dependent on vagal 
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tone and modulates heart rate in response to breathing, activity, wakefulness, and 
sleep (Hartikainen et al., 1996; Stein and Kleiger, 1999; Gordan et al., 2015; 
Shaffer and Ginsberg, 2017). In addition to the SDNN and RMSDD (i.e. time 
domain parameters), HRV can be analyzed via frequency domain parameters (i.e. 
low frequency, high frequency) (Stein and Kleiger, 1999). The frequency domain 
provides information regarding the amount of variance in heart rhythms explained 
by oscillations in heart rate at various frequencies allowing for the interpretation of 
autonomic balance (Stein and Kleiger, 1999). High frequency (HF) power is 
mediated by vagal tone and respiratory sinus arrhythmia, while low frequency (LF) 
power is mediated by a combination of parasympathetic tone, sympathetic tone, 
and the baroreflex response (Hyndman et al., 1971; Pomeranz et al., 1985; Fallen 
et al., 1988; Stein and Kleiger, 1999; Jansen and Lagae, 2010). There have been 
several studies that found alterations in measurements of HRV in individuals with 
epilepsy and concluded that it may be associated with SUDEP (Harnod et al., 
2008; DeGiorgio and DeGiorgio, 2010; Toth et al., 2010; Lotufo et al., 2012; Sarkis 
et al., 2015; Sivakumar et al., 2016; DeGiorgio et al., 2017; Stollberger and 
Finsterer, 2017). The majority of these studies have found either a decrease in 
vagal tone with an increase in sympathetic drive after a GTCS (Sarkis et al., 2015; 
Sivakumar et al., 2016), with one study finding that this persisted 5-6 hours post-
seizure (Toth et al., 2010). When examining inter-ictal HRV, the research shows 
that time and frequency domain measures are lower, suggestive of a reduction in 
vagal tone and long-term autonomic imbalance in individuals with epilepsy 
(Ansakorpi et al., 2000; Ansakorpi et al., 2002; Harnod et al., 2008). These data 
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also suggest that epilepsy impacts autonomic function outside of the pre-ictal, ictal, 
and post-ictal periods. There have also been a few studies stating that there is no 
association between autonomic dysfunction, epilepsy, and SUDEP (Persson et al., 
2007; Lee et al., 2013). One study found that while there was a decrease in heart 
rate just prior to a nighttime seizure, there were no post-ictal changes in heart rate, 
leading to the conclusion that there was no evidence that SUDEP is associated 
with postictal autonomic dysfunction (Lee et al 2013). Additionally, an older study 
found that there were no changes in time or frequency measurements in 
individuals with untreated epilepsy (Persson et al., 2007). There was another study 
that examined respiratory sinus arrhythmia (RSA) and heart rate in adolescents 
with epilepsy and found that in 5 of the non-epileptic individuals had increased 
RSA and decreased heart rate, suggestive of autonomic imbalance and were later 
diagnosed with epilepsy (Sivakumar et al., 2016). This suggests that autonomic 
dysfunction may precede the onset of epilepsy and may be a useful predictive 
marker for SUDEP. Many studies have also found changes in cardiac function in 
individuals with epilepsy who have not been diagnosed with any prior cardiac 
dysfunction (Surges et al., 2010; Velagapudi et al., 2012; Massey et al., 2014; 
Dlouhy et al., 2016). While overall, the data suggest that autonomic and cardiac 
dysfunction occurs in individuals with epilepsy, alterations in the function of 
brainstem neurons that regulate autonomic output should be investigated to 
determine if changes in their function are associated with autonomic imbalance 
and SUDEP. 
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1.3 Genetic Models of SUDEP 
1.3.1 Dravet’s Syndrome 
Developing genetic models of epilepsy where the animals suffer from 
SUDEP has been popular due to the ease of gene deletion that leads to a seizure 
phenotype. Two of the most well-established models are the Dravet’s syndrome 
(DS) and the KCNA1-null mouse. DS is an epilepsy channelopathy characterized 
by mutations in the voltage-gated Na+ channel, Nav1.1, which is encoded by the 
SCN1A gene. There are several different mutations in the SCN1A gene can that 
lead to altered function in Nav1.1 and epilepsy. These mutations can occur in the 
regions of the gene that encode for any part of the six transmembrane spanning 
unit that comprises the channel and/or on the C- and N-termini (Catterall et al., 
2010; Catterall, 2012). Additionally, complete deletion of SCN1A in humans and 
mice is embryonically lethal (Catterall et al., 2010). These mutations can be 
responsible for various forms of inherited epilepsies, including DS (Escayg et al., 
2000; Catterall et al., 2010).  Individuals with DS suffer from SUDEP and display 
depressed HRV and abnormal cardiac rhythms (Le Gal et al., 2010; Delogu et al., 
2011; Sakauchi et al., 2011; Goldman et al., 2016). In mouse models, the mutation 
known to cause Dravet’s Syndrome in humans was introduced into the SCN1A 
gene to create reduced Nav1.1 channel function, subsequently leading to a 
spontaneous seizure phenotype (Yu et al., 2006; Oakley et al., 2009; Oakley et al., 
2011; Cheah et al., 2012; Auerbach et al., 2013; Kalume et al., 2013; Ogiwara et 
al., 2013; Aiba and Noebels, 2015). In this model, mice begin to have spontaneous 
seizures by postnatal day 21 and sudden death begins to occur around postnatal 
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day 23 (Yu et al., 2006; Ogiwara et al., 2007; Cheah et al., 2012; Kalume et al., 
2013). DS mice have a decrease in the density of GABA interneurons, reduced 
Na+ current, and action potential firing without any changes in excitatory neurons 
(Yu et al., 2006; Cheah et al., 2013). The imbalance between inhibition and 
excitation may be responsible for the seizure phenotype. Additionally, these mice 
display altered cardiorespiratory function, such as QT prolongation, bradycardia, 
suppressed inter-ictal HRV, and gasping (Kalume et al., 2013; Aiba and Noebels, 
2015). It has been hypothesized that significant post-ictal bradycardia due to 
increased vagal tone contributes to SUDEP in DS (Kalume et al., 2013). This 
model implicates the involvement of central autonomic neurons, because animals 
have cardiac dysfunction, even in a GABA forebrain neuron specific knockout 
(Kalume et al., 2013). Additionally, causing seizures to spread from the cortex to 
brainstem leads to cardiorespiratory collapse and sudden death (Aiba and 
Noebels, 2015). This model has provided significant insight into potential 
mechanisms for SUDEP, but it only affects a small percent of the total epilepsy 
population. 
1.3.2 Potassium Channel Mutations 
Another common genetic model of epilepsy is the KCNA1-null mouse 
model. This involves the deletion of the KCNA1 gene that encodes the Kv1.1 
voltage-gated K+ channel (Glasscock et al., 2010; Moore et al., 2014; Gautier and 
Glasscock, 2015; Simeone et al., 2018). Kv1.1 is expressed in the brain and the 
vagus nerve (Glasscock et al., 2010; Glasscock et al., 2012; Glasscock, 2013; 
Goldman et al., 2016). In addition to displaying an epilepsy phenotype, Kv1.1 
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knockout mice die suddenly and prematurely (Smart et al., 1998; Glasscock et al., 
2007; Glasscock et al., 2010). They also have a high frequency of atrio-ventricular 
(AV) blocks that can be prevented by atropine administration, suggestive of 
autonomic imbalance (Glasscock et al., 2010). Additionally, Kv1.1 mice display 
hyperexcitability in axons from the mouse vagus nerve, indicative of increased 
excitatory transmission to central autonomic neurons (Glasscock et al., 2012). 
These mice also have increased respiratory drive and apnea (Simeone et al., 
2018). Although this study showed that respiratory dysfunction occurs in Kv1.1 
knockout mice, the authors did not show that sudden death occurred in concert 
with respiratory dysfunction. Researchers have also shown that increased 
activation of KCNQ2, which encodes the Kv7.2 potassium channel, in vagal nerve 
fibers rescues hyperexcitability seen in Kv1.1 knockout mice (Glasscock et al., 
2012) and that SCN2A deletion improves survival rates in Kv1.1 knockout mice 
(Mishra et al., 2017). 
 Another genetic epilepsy model for SUDEP introduces a mutation into 
KCNQ1 gene that encodes the Kv7.1 channel, one of the most common genes for 
long-QT syndrome in humans. Individuals with long-QT are at high risk for sudden 
death due to their propensity to have fatal ventricular arrhythmias (Goldman et al., 
2016). When a dominant point mutation is introduced into the gene, it reproduces 
the human phenotype and these mice display dysfunctional neuronal 
repolarization, seizures, and sudden death (Goldman et al., 2009). The 
examination of genes encoding voltage-gated K+ channels in the brain and the 
heart has provided valuable insight into how their dysfunction contributes to 
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epileptogenesis, autonomic dysfunction and SUDEP, however it is difficult to 
separate the genetic mutation from the seizures and sudden death. 
1.3.3 Audiogenic Seizure Models  
Researchers have used DBA/1 and DBA/2 mice to study mechanisms of 
SUDEP because they are susceptible to seizures when exposed to high-intensity 
acoustic stimulation (i.e. audiogenic seizures) (Faingold et al., 2010). Faingold et 
al. has shown that an audiogenic seizure leads to respiratory arrest in 30% of these 
mice (Faingold et al., 2010). However, this study did not complete any quantitative 
respiratory measures and only visual assessment of the chest rising and falling 
was done. Administration of SSRIs in these mice reduced the incidence of seizure-
induced respiratory arrest (Tupal and Faingold, 2006; Zeng et al., 2015; Faingold 
et al., 2016). These mice also displayed altered expression of 5-HT receptors in 
the caudal brainstem (Uteshev et al., 2010). However, there are several pitfalls 
with this model: 1) they do not develop spontaneous seizures; 2) mice sometimes 
die after the first seizure, which does not meet the criteria for SUDEP; 3) It does 
not appear that autonomic dysfunction has been examined in this model. While 
genetic models of epilepsy have been informative to the field of SUDEP, they are 
lacking in that they only apply to a very small percent of individuals with epilepsy. 
Acquired epilepsies, (i.e. not caused by genetic mutations), affect a much larger 
percentage of individuals with epilepsy who are at risk for SUDEP and acquired 
epilepsy mouse models need to be utilized to determine biomarkers and 
preventative options for these individuals as well. 
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1.4 Acquired Epilepsies 
1.4.1 Definitions and Epidemiology 
Acquired epilepsies are broadly defined as a neurological disorder that is 
initiated by some type of insult to the brain (Delorenzo et al., 2005; Dudek and 
Staley, 2012). While epilepsy affects 1-2% of the population, about half of those 
individuals have acquired epilepsy (Delorenzo et al., 2005; McNamara and 
Scharfman, 2012). The other 50% of epilepsies are either idiopathic (i.e. no known 
cause in the absence of brain abnormalities) or genetic (Delorenzo et al., 2005). 
In acquired epilepsy, there is typically a known cause of the neurological insult that 
induces a permanent change in a previously normal brain leading to the 
development of epilepsy (Delorenzo et al., 2005). This occurs in 3 phases: the 
initial insult, the latent period of epileptogenesis, and spontaneous recurrent 
seizures (Delorenzo et al., 2005). 
1.4.2 Temporal Lobe Epilepsy 
The most common type of acquired epilepsy is TLE which affects 60% of 
all individuals with epilepsy according to the Epilepsy Foundation. TLE involves an 
imbalance in the excitatory and inhibitory networks within the temporal lobe. This 
includes the hippocampus, amygdala, auditory cortex, and the entorhinal cortex. 
TLE is form of partial or focal epilepsy that can be further split into 2 types: medial 
TLE and neocortical TLE. Medial TLE is the most common of the two (Tellez-
Zenteno et al., 2005; McNamara and Scharfman, 2012). While there is little 
research done on the epidemiology of TLE, the reported incidence is 10.4 per 
100,000 individuals (Tellez-Zenteno and Hernandez-Ronquillo, 2012). 
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1.4.3 Pathophysiology of TLE 
As in acquired epilepsy, an initial insult followed by a latent period 
culminates in recurrent seizure pathology (White, 2012). The pathogenesis of TLE 
is progressive in nature and it is hypothesized that synaptic reorganization and a 
disruption in the balance of excitation and inhibition play key roles in the 
development of spontaneous seizures (Dudek and Staley, 2012). The death of 
GABAergic interneurons directly following the insult and during the latent phase is 
hypothesized to be responsible for decreases in GABA-mediated inhibition, 
allowing for increases in network excitation (Kobayashi and Buckmaster, 2003; 
Ben-Ari and Dudek, 2010; Dudek and Staley, 2012). Axon sprouting also 
contributes to the development of increased excitation in TLE (de Lanerolle et al., 
1989; Sutula et al., 1989; Dudek and Staley, 2012), as the majority of these nerve 
connections are excitatory.  
1.5 Animal Models of TLE 
1.5.1 Electrical Kindling 
Kindling is a process that consists of daily electrical stimuli delivered to brain 
structures such as the amygdala or hippocampus. When repeated over time, this 
induces a generalized convulsive seizure and mice eventually develop a shorter 
latency to seize as a response to stimulation. However, it is still debated if kindling 
accurately reflects the human condition since rodents do not develop recurrent 
spontaneous seizures (Loscher and Brandt, 2010).  In terms of changes to cellular 
pathology, increased recurrent excitation and altered GABA interneuron 
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dysfunction does occur in this model (Lynch and Sutula, 2000; Sutula and Dudek, 
2007; White, 2012). 
1.5.2 Kainic-Acid Model 
Kainic acid (KA) is an excitatory neurotransmitter agonist that activates 
glutamate receptors and produces cell death via excitotoxicity when administered 
to rodents (Cronin and Dudek, 1988). A single injection of KA leads to seizure 
development in 50% of rats (Cronin and Dudek, 1988) and multiple low-dose 
injections of KA leads to SE and subsequent TLE in 75-90% of rats (Hellier et al., 
1998; Hellier and Dudek, 2005; Williams et al., 2009). Recurrent neuronal 
excitation and synaptic reorganization also occurs in this model. However, some 
mouse strains, such as C57BL/6 and BALB/c mice, are more resistant to KA-
induced cell death and degeneration at single and multiple injections 
(Schauwecker and Steward, 1997; McKhann et al., 2003). Recurrent seizure 
activity can reliably occur when KA is injected directly into the hippocampus 
(Bouilleret et al., 1999), although this technique is more invasive than 
intraperitoneal injections.  
1.5.3 The Pilocarpine-Induced Status Epilepticus Model of TLE 
The pilocarpine-induced status epilepticus (pilo-SE) model of TLE was 
discovered to cause an initial period of severe seizures by Turski et al. in the early 
1980’s. They observed that administration of pilocarpine results in a 1-2 hour 
period of behavioral limbic seizures (Turski et al., 1983; Turski et al., 1984). It was 
later found that following a latent period of 4-6 weeks, mice that developed SE, 
also developed spontaneous seizures (Turski et al., 1989; Cavalheiro et al., 1994; 
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Cavalheiro et al., 1996; Shibley and Smith, 2002; Winokur et al., 2004). About 30-
40% of mice develop SE from the pilocarpine injection, there is  an ~30% mortality 
rate, and the rest of the mice that do not have SE do not develop spontaneous 
seizures (Shibley and Smith, 2002).  
 The pilo-SE model of TLE will be used in this dissertation because it more 
accurately models the human form of TLE. Additionally, various mouse strains 
reliably develop spontaneous seizures, whereas other models vary across strain 
in terms of TLE development. It follows the previously set forth hypothesis of an 
initial insult, followed by a latent period, and then spontaneous seizures. 
Pilocarpine has been shown to induce cell death within a few days of 
administration (Kobayashi and Buckmaster, 2003). Research has suggested 
eventual development of recurrent seizures in this model is associated with 
synaptic reorganization and aberrant sprouting in the hippocampus (Dudek and 
Spitz, 1997; Dudek, 2002). Additionally, pilocarpine causes an insult in the same 
structures within the temporal lobe that are affected in individuals with TLE. There 
are mouse strain differences in the mortality and cell death in the hippocampus 
following the pilocarpine treatment (Schauwecker, 2012). For the purposes of this 
dissertation, mouse strains were used that have been well-established to develop 
chronic spontaneous seizures or were monitored for seizure activity (Shibley and 
Smith, 2002; Winokur et al., 2004; Bhaskaran and Smith, 2010b). 
1.6 Significance of SUDEP in Individuals with TLE 
About 60% of all individuals with epilepsy have TLE and about half of those 
individuals have refractory TLE. Refractory TLE is defined by the Epilepsy 
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Foundation as seizures that are not controlled by medications. In this case, the 
individual has failed to become and stay seizure free with two or more trials of 
AEMs. In fact, refractory epilepsy is one of the biggest SUDEP risk factors 
(Tomson et al., 2008; Lhatoo et al., 2010b). Additionally, individuals with refractory 
TLE have a higher frequency of seizures compared to those on AEMs, placing 
them at an even higher risk for sudden death (Devinsky, 2011; Lamberts et al., 
2012; Tolstykh and Cavazos, 2013; Thurman et al., 2014). 
 There have been several studies showing that individuals with TLE have 
cardiac and autonomic dysfunction. Increases in heart rate can occur in children 
and adolescents with TLE (Mayer et al., 2004) and in newly diagnosed individuals, 
who show ictal sympathetic overdrive, indicative of autonomic imbalance (Romigi 
et al., 2016). While the evidence in patient studies is suggestive of autonomic and 
cardiac dysfunction, it is conflicting as to whether this is associated with an 
increase in sympathetic drive, a decrease in vagal tone or a combination of both 
leads to autonomic imbalance. Many studies have found there to be an increase 
in the time and frequency measurements of HRV, including impaired baroreflex 
sensitivity potentially contributing to SUDEP risk (Dutsch et al., 2006; Romigi et 
al., 2016). Others have observed a decrease in HRV, indicative of a decrease in 
vagal tone (Massetani et al., 1997; Tomson et al., 1998; Ansakorpi et al., 2002; 
Ronkainen et al., 2005; Jansen and Lagae, 2010; Surges et al., 2010; Suorsa et 
al., 2011). HRV measurements seem to improve if TLE is controlled by medication 
or surgery (Tomson et al., 1998; Hilz et al., 2002; Suorsa et al., 2011). Suorsa et 
al. measured heart rate and HRV in individuals with TLE and in a follow-up study 
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6 years later found that individuals with refractory TLE had decreased HRV over 
time (Suorsa et al., 2011). This suggests that recurrent seizure activity has a 
progressive effect on worsening autonomic imbalance. Many studies have also 
found that individuals with TLE have ictal tachycardia, increased ictal and post-
ictal heart rate, arrhythmia, and pathologic repolarization, suggestive of cardiac 
dysfunction (Massetani et al., 1997; Jansen and Lagae, 2010; Surges et al., 2010). 
HRV and vagal suppression may also have a circadian component, as individuals 
with TLE have more pronounced HRV suppression at night compared to healthy 
individuals (Ronkainen et al., 2005). Interestingly, no respiratory abnormalities 
were found in individuals with TLE, but respiration was only measured in the inter-
ictal periods (Scorza et al., 2007). Additional evidence linking TLE to brainstem 
dysfunction regulating autonomic output comes via functional MRI studies. There 
was found to be lower connectivity from the temporal lobe to the ARAS and 
brainstem in TLE individuals at high risk for SUDEP (Allen et al., 2017; Englot et 
al., 2017a). Studies examining pilocarpine-induced SE in rodents also suggest 
cardiac and autonomic imbalance occurs. In acute pilocarpine-induced SE, there 
is an increase in heart rate and blood pressure in the hour following SE (Metcalf et 
al., 2009b; Metcalf et al., 2009a). This suggests that an increase in sympathetic 
drive occurs in the weeks following pilo-SE. Another study found altered autonomic 
control of heart rate in rats 1-2 weeks after pilo-SE (Bealer et al., 2010). This 
alteration in sympathovagal balance may increase the risk for arrhythmia and 
sudden death. However, there has been a paucity of studies examining the effect 
of spontaneous recurrent seizures in the pilocarpine-induced SE (i.e. pilo-SE) 
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model of TLE in relation to SUDEP. The focus of this dissertation will be on the 
association between the pilo-SE model of TLE, central autonomic dysfunction, and 
SUDEP. 
1.7 The Vagal Complex 
1.7.1 Vagal Complex Anatomy 
The vagal complex is located in the caudal brainstem and is a critical central 
regulator of autonomic function. Viscerosensory inputs from the afferent fibers of 
the vagus, glossopharyngeal, and facial nerves end in a bundle of primary sensory 
fibers called the solitary tract (ST). The ST also conveys information from the 
baroreceptors and chemoreceptors in the cardiovascular and respiratory systems. 
The terminals of the ST release glutamate onto neurons within the nucleus tractus 
solitarius (NTS). The NTS contains a heterogeneous population of both GABAergic 
and glutamatergic neurons. These neurons serve as critical filters, integrators, and 
modulators of sensory afferent information in order to regulate sympathetic and 
parasympathetic output to the periphery. NTS neurons project their axons to 
preganglionic parasympathetic motor neurons in the DMV and NA (Andresen and 
Kunze, 1994; Doyle and Andresen, 2001; Wang et al., 2001a; Travagli et al., 2006; 
Bailey et al., 2008). Glutamatergic neurons are responsible for the regulation of 
sympathetic output of cardiac activity. Their axons project and synapse to inhibitory 
neurons in the CVLM. CVLM neurons project to the RVLM, which send 
glutamatergic fibers to preganglionic neurons in the spinal cord (Gordan et al., 
2015). Glutamatergic NTS neurons also regulate the DMV by providing phasic 
excitation (Travagli et al., 1991; Gao and Smith, 2010). 
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 GABAergic NTS neurons maintain tonic inhibition that aids in the regulation 
of vagal outflow (Davis et al., 2004; Travagli et al., 2006). About 20% of neurons 
in the DMV influence the regulation of vagal tone to the periphery. The rest of the 
GABA NTS neurons project to cardiac vagal motor neurons (CVMNs) in the 
nucleus ambiguus (NA). CVMNs are motor neurons that synapse onto 
postganglionic neurons in the cardiac ganglia at the base of the heart (Kunze and 
Ritchie, 1990; Dergacheva et al., 2013). Vagal circuit plasticity has been shown to 
occur in other disease states that affect autonomic regulation of homeostasis (Mei 
et al., 2003; Bach et al., 2015; Boychuk et al., 2015a). It therefore stands to reason 
that vagal complex neurons may have altered function in response to 
epileptogenesis, especially since patient data suggests altered autonomic function 
in TLE (Ronkainen et al., 2005; Romigi et al., 2016).  
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Figure 1.1 Schematic of vagal complex circuitry.  
NTS = nucleus tractus solitarius; DMV = dorsal motor nucleus of the vagus 
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1.7.2 Characteristics of GABA NTS Neurons 
GABAergic neurons make up a large proportion of NTS neurons and are 
interspersed throughout the lateral and medial NTS (Blessing, 1990; Minson et al., 
1997; Fong et al., 2005). While GABA NTS neurons project to the DMV and NA, 
they can also act as local interneurons, inhibiting NTS signaling (Davies et al., 
1987; Ezure and Tanaka, 1996; Davis et al., 2004; Kubin et al., 2006; Travagli et 
al., 2006). The medial NTS tends to receive major input from arterial baroreceptors 
(Andresen and Kunze, 1994; Andresen and Yang, 1995). Lateral NTS neurons 
also play a role in respiratory regulation (Wasserman et al., 2002). 
 GABA is synthesized from glutamate via the enzyme glutamate 
decarboxylase (GAD). GAD is present only in cells that use GABA as a 
neurotransmitter (Simon et al., 1985; Erlander and Tobin, 1991; Roth and 
Draguhn, 2012). Cytosolic GABA is shuttled into vesicles by vesicular GABA 
transporter (VGAT), which is highly concentrated in presynaptic terminals 
(Chaudhry et al., 1998; Jin et al., 2003). When a depolarization of the presynaptic 
neuron prompts the release of the GABA into the synaptic cleft, GABA binds to 
postsynaptic receptors, hyperpolarizing the postsynaptic neuron. GABA’s action is 
terminated via reuptake into the presynaptic terminals and/or nearby glial cells. 
Then GABA can be degraded by GABA transaminase into glutamate and succinic 
semialdehyde (Roth and Draguhn, 2012).  
 GABA NTS neurons are important to many processes for autonomic 
homeostasis as they are central integrators of peripheral cardiovascular, 
respiratory, and gastrointestinal systems. GABA NTS neurons are able to directly 
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modulate heart rate, as microinjection of GABA antagonists into the NA decreases 
heart rate (DiMicco et al., 1979; Wang et al., 2001a). GABA NTS neurons also play 
a role in hypoxia and respiration (Accorsi-Mendonca et al., 2015), gastrointestinal 
regulation, and glucose sensing (Browning et al., 2002; Bach and Smith, 2012; 
Boychuk et al., 2015b; Boychuk et al., 2017). 
1.8 Voltage-Gated K+ Channels 
1.8.1 Structure and Function of Voltage-Gated K+ Channels 
Voltage-gated K+ (Kv) channels are widely expressed in the brain and 
throughout the central and peripheral nervous system (Coetzee et al., 1999; 
Birnbaum et al., 2004; Villa and Combi, 2016). The human genome contains at 
least 100 different Kv channel subunits (Cooper, 2012). All Kv channels and their 
variants are built similarly with six transmembrane spanning (TM) domains. The 
ion conducting pore is made up of four polypeptide domains arranged around a 
central water-filled transmembrane region. There are four pore-forming segments 
with intracellular N- and C-termini, 2 transmembrane segments, and an 
extracellular loop that partially dips into the pore acting as a K+ selectivity filter. 
There is also a very short, highly conserved length of polypeptide that allows for 
the movement of the voltage-sensor by pulling open the pore during depolarization, 
and pushing it closed at rest (Cooper, 2012). Humans have 36 6TM Kv channel 
subunit genes that vary in their biophysical properties (Coetzee et al., 1999; 
Cooper, 2012). 
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Figure 1.2 Schematic of Kv4 ion channel 
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Kv4 channels are one subfamily of the voltage-gated K+ channels that are 
in both the cortex and the NTS. There are 3 different Kv4 subtypes: Kv4.1, Kv4.2, 
and Kv4.3 (Birnbaum et al., 2004). These channels influence neuronal firing 
properties and cellular excitability (Jerng et al., 2004; Covarrubias et al., 2008; 
Strube et al., 2015). Various K+ channel subunits have been found to modulate 
Kv4 activity. The most well-characterized of those subunits are known as K+ 
channel interacting proteins (KChIPs). KChIPs are neuronal calcium sensors that 
have a variable amino acid terminal domain and a conserved carboxyl terminal 
with calcium binding motifs (Birnbaum et al., 2004). There are 4 different types of 
KChIPs (KChIP1, KChIP2, KChIP3, KChIP4) that are found in the brain and 
colocalize with the Kv4 family of channels (Birnbaum et al., 2004; Jerng et al., 
2004). KChIP1-4 have been shown to colocalize with all members of the Kv4 family 
in a nonspecific manner (An et al., 2000; Bahring et al., 2001; Birnbaum et al., 
2004; Covarrubias et al., 2008; Cheng et al., 2016). When co-expressed with Kv4 
channels, KChIPs increase current density by increasing the surface expression 
Kv4 channels (Birnbaum et al., 2004; Jerng et al., 2004; Covarrubias et al., 2008; 
Schwenk et al., 2008). Additionally, KChIPs can alter the kinetics of activation and 
inactivation of Kv4 channels, such as hyperpolarizing the activation curve, quicken 
recovery from inactivation, and slowing the rate of inactivation (Birnbaum et al., 
2004; Covarrubias et al., 2008). KChIPs can also promote channel trafficking to 
the membrane (An et al., 2000; Jerng et al., 2004; Covarrubias et al., 2008). 
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1.8.2 Association with TLE 
While there are many Kv subtypes that have been associated with epilepsy 
in humans and animals, this dissertation places particular focus on the Kv4 
subfamily (D'Adamo et al., 2013; Villa and Combi, 2016). The Kv4 subfamily has 
been shown to be associated with human epilepsies and it is also expressed in the 
vagal complex (Singh et al., 2006; Smets et al., 2015; Villa and Combi, 2016).  
Voltage-gated K+ (Kv) channels have been shown to be altered in individuals with 
epilepsy with TLE (Singh et al., 2006; Villa and Combi, 2016).  Kv channels play a 
major role in neuronal excitability and K+ channelopathies can contribute to 
seizures (Brenner and Wilcox, 2012; D'Adamo et al., 2013; Villa and Combi, 2016). 
A truncated Kv4.2 subunit has been found to cause seizures in a patient case study 
(Singh et al., 2006) and other gain of function mutations in Kv4.2 were found in 
intractable epilepsy (Smets et al., 2015). 
 Kv4 channels are essential for the regulation of neuronal excitability, 
specifically modulating the A-type current (IA). The modulation of IA is crucial in the 
repolarization phase of the action potential and prevents action potential back 
propagation. Bernard et al. has shown hippocampal neurons from pilo-SE mice 
have decreased Kv4.2 subunit expression and altered IA (Bernard et al., 2004). 
However, in this study, there was no mention of how long the mice had 
spontaneous seizures prior to being used in their experiments. This is crucial as 
many rodents develop spontaneous seizures at different time points (Shibley and 
Smith, 2002), which may have an effect on Kv4.2 expression. A separate study 
found a decrease in Kv4.2 and KChIP2 expression in the hippocampus 4 and 12 
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weeks after pilo-SE treatment (Monaghan et al., 2008). Another study measured 
Kv4.2 expression in the chronic spontaneous seizure phase and found that there 
was a decrease in Kv4.2 and KChIP1 protein levels in the hippocampus (Su et al., 
2008). Alterations in these channels have yet to be investigated in brain regions 
outside of the hippocampus in a mouse model of TLE. 
Kv4 subtypes and IA have been shown to be expressed in the NTS and be 
altered in pathological states. IA modulates synaptic transmission to other vagal 
complex pathways, current amplitude, activation kinetics, and protects against 
excitotoxicity (Bailey et al., 2002; Yang et al., 2005; Bailey et al., 2007; Covarrubias 
et al., 2008; Strube et al., 2015). In pathological states, IA has been shown to be 
altered in hypertension (Sundaram et al., 1997; Belugin and Mifflin, 2005). 
Additionally, pharmacologic blockade of IA modulates electrophysiological 
properties of NTS neurons and attenuates baroreflex regulation of heart rate 
(Butcher and Paton, 1998). Therefore, if the NTS altered during TLE, IA may also 
have altered function as well. 
1.9 Study Aims and Significance 
This study will focus on the association between the pilo-SE induced model 
of TLE, central control of autonomic function, and SUDEP. This study will further 
focus on alterations in GABA NTS neuron function during epileptogenesis. Other 
studies examined cardiac function acutely following pilocarpine; therefore, this 
study will have longer time points allowing for the investigation of long-term effects 
of epilepsy development with chronic spontaneous seizures on cardiac and GABA 
NTS function. The investigation into mechanisms of SUDEP in TLE could lead to 
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the development of SUDEP biomarkers or preventative treatments in an under-
researched population that is at high risk for SUDEP. The hypothesis that the 
pilocarpine-induced SE model of TLE is associated with SUDEP, altered cardiac, 
and alterations in the synaptic and functional properties of GABAergic NTS 
neurons was tested. 
 The specific aims of this project are as follows: 
1) Determine if pilo-SE mice suffer from SUDEP with related changes in 
cardiac and GABA NTS neuron function.  Because the pilocarpine-
induced SE model of TLE has not been used to study SUDEP, it was first 
determined if pilo-SE mice die suddenly in the weeks following survival from 
the initial pilocarpine-induced SE. Cardiac and autonomic dysfunction 
occurs in individuals with TLE, thus ECG was used to investigate these 
factors in the weeks following pilocarpine-induced SE. Lastly, as GABAergic 
NTS neurons directly modulate autonomic output to the periphery, 
electrophysiology was used to assess their function 1, 6, and 12 weeks after 
pilocarpine-induced SE. 
2) Determine if Kv4 subunits and IA are altered in the pilo-SE model of 
TLE in GABA NTS neurons. Immunohistochemistry and western blot have 
shown that Kv4 subunits are downregulated in the hippocampus following 
pilocarpine-induced SE. No studies have assessed alterations in Kv4 
expression or IA in the context of TLE within vagal complex. Whole-cell 
patch-clamp electrophysiology was used to measure action potential 
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frequency and half-width, and to isolate IA density. Differential expression 
of Kv4.1, Kv4.2, Kv4.3 and KChIPs1,3, and 4 was also measured.  
3) Utilize chemogenetic manipulation of GABA NTS neurons to 
determine if activation of these neurons can alter seizure threshold. 
Designer receptors exclusively activated by designer drugs (DREADDs) 
have been shown to selectively excite or inhibit specific neuronal subtypes 
in order to modulate both animal behavior and neuronal function. The 
excitatory DREADD, pAAV8-hSyn-DIO-hM3D(Gq)-mCherry, was used to 
selectively excite GABAergic NTS neurons in pilo-SE mice. In vivo studies 
were done to determine if behavioral seizures could be elicited via DREADD 
activation or if seizure latency could be modulated. Electrophysiology was 
used to determine the effect of DREADD activation on firing properties of 
GABA NTS neurons and synaptic properties of local DMV neurons. 
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Chapter 2 Materials and Methods 
2.1 Mice 
 For the survival study and in vivo electrocardiography (ECG) in Chapter 3, 
5 week old male CD-1 mice (Harlan Laboratories were used). For 
electrophysiology studies in Chapters 3 and 4, 4-6 week old male Green Inhibitory 
Neuron (i.e. GIN; FVB-Tg (GADGFP) 4570Swn/J; The Jackson Laboratory) was 
used. GIN mice utilize GFP as a fluorescent reporter for somatostatin expressing 
GABAergic neurons within the NTS, which allows for the targeted recording of 
these neurons (Oliva A.A. et al., 2000). For chemogenetic studies in Chapter 5, 4-
6 week old male Slc32a1tm2(cre)Lowl/J (i.e. Vgat-ires-cre; The Jackson Laboratory) 
were used. Vgat-ires-cre mice express cre recombinase activity in GABAergic 
neurons without interrupting endogenous vesicular GABA transport activity. All 
procedures were approved by the University of Kentucky Animal Care and Use 
Committee and NIH guidelines were adhered to for the care and use of animals. 
All animals were housed in Association for Assessment and Accreditation of 
Laboratory Animal Care approved facilities, on a 14:10 light:dark cycle with food 
and water available ad libitum.  
2.2 The Pilocarpine-Induced Model of TLE 
 TLE was induced in all experimental mice following procedures similar to 
that of Shibley and Smith 2002 (Shibley and Smith, 2002). First, all mice were 
given an intraperitoneal (i.p.) injection of methylscopolamine (1 mg/kg in 0.9% 
saline). Methylscopolamine is a muscarinic antagonist that does not cross the 
blood brain barrier and its administration serves to reduce the peripheral 
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convulsant effects of pilocarpine. After 20 minutes, mice were given either an i.p. 
injection of pilocarpine (280-285 mg/kg in 0.9% saline) or vehicle (0.9% saline). 
Pilocarpine is a tertiary amine that readily crosses the blood brain barrier and acts 
as a nonselective muscarinic receptor agonist (Geller, 1984). Twenty to 30 minutes 
after pilocarpine injection, mice began to display behavioral seizures which are 
rated on based on a modified Racine scale, from category 1-5, with 5 being the 
most severe (Racine, 1972). All mice were monitored for behavioral seizures for 2 
hours post-injection. Category 1 and 2 consist of tail-stiffening, freezing, wet dog 
shakes, and facial automatisms. All mice exhibited some or all of these behaviors. 
Category 3 (i.e. unilateral forelimb myoclonus), category 4 (i.e. bilateral forelimb 
myoclonus and rearing), and category 5 (i.e. bilateral fore- and hindlimb myoclonus 
and transient loss of postural control) were considered to be generalized 
convulsive seizures. Seizures were typically 30-90 seconds in duration and 
separated by periods of relative inactivity. Mice that displayed a minimum of 3 
category 3-5 seizures were considered to have undergone status epilepticus (SE) 
and were subsequently classified as pilo-SE mice. Greater than 90% of pilo-SE 
mice went on to develop spontaneous seizure activity 4-6 weeks post-injection 
(Shibley and Smith, 2002; Winokur et al., 2004; Bhaskaran and Smith, 2010b).  No 
seizure activity was observed in control mice at any time post-injection.  
In addition to standard diet, mice were given water-moistened food and a 
5% glucose solution in their cage for 4 days post-treatment. Animals were also 
given diet gel to supplement their standard chow and aid in avoiding dehydration. 
Animals were weighed twice a day for 4 days following SE. If an animals weight 
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decreased by more than 20% following SE and they did not recuperate following 
subcutaneous ringer solution injections, they were euthanized.  
A small cohort of GIN mice were observed two weeks prior to their use in 
electrophysiology experiments for behavioral seizure activity. Mice were observed 
for 2 hours, 3 times per week (Shibley and Smith, 2002; Winokur et al., 2004; Hunt 
et al., 2013). Using this same protocol, behavioral observation for seizures were 
conducted in a small cohort of Vgat-ires-cre animals in order to establish that they 
developed chronic spontaneous seizures, as some mouse strains are resistant to 
seizure morphology (Schauwecker, 2012). 
2.3 Brainstem Slice Preparation 
 Patch-clamp recordings were made in brainstem slices from mice. Mice 
were deeply anesthetized via inhalation of isofluorane to effect (i.e. lack of 
response to toe-pinch) and decapitated. The brain was removed and placed into 
ice-cold (2-4 C) artificial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 
3 KCl, 2 CaCl2, 1.3 MgCl2, 1.4 NaH2PO4, 26 NaHCO3, and 11 glucose (pH 7.2-
7.4). The brain was blocked on an ice-cold stand and glued on a platform for 
sectioning in the coronal plane. Transverse 300 m thick sections from the caudal 
brainstem were made in cold ACSF using a vibrating microtome (Vibratome series 
1000; Technical Products International) and transferred to a holding chamber 
containing warmed (30-32C) oxygenated ACSF. Slices were incubated for at least 
one hour in the holding chamber prior to use in electrophysiological experiments. 
These brainstem slices contain the NTS and DMV and preserve primary afferent 
connections in the solitary tract.  
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2.4 Electrophysiological Recordings 
 Brainstem slices were transferred to a chamber mounted on a fixed stage 
under an upright microscope (BX51WI; Olympus, Center Valley, PA), where it was 
superfused with continuously warmed (30-32C) oxygenated ACSF. Somatostatin 
containing GABAergic EGFP neurons were targeted under epifluorescence. Patch 
pipettes for recordings were pulled from borosilicate glass (open tip resistance 3-
5 M; King Precision Glass Co, Claremont, CA). The pipette solution contained 
(in mM): 130 K+ gluconate, 1 NaCl, 5 EGTA, 10 HEPES, 1 MgCl2, 1 CaCl2, 3 KOH, 
and 2 ATP. Recordings were obtained using an Axon 700B amplifier (Molecular 
Devices, San Jose, CA), low pass filtered at 2-3 kHz, digitized at 20 kHz, and 
recorded onto a computer (Digidata 1440A, Molecular Devices). Seal resistance 
was between 2 and 5 G for on-cell and whole-cell recordings.  
 On-cell patch-clamp recordings of spontaneous action potentials were 
recorded in voltage clamp mode at resting membrane potential in GABAergic NTS 
neurons. For whole-cell patch-clamp recordings, cells were voltage-clamped at       
-70 mV and allowed to equilibrate with the pipette recording solution for 
approximately five minutes. Spontaneous and miniature excitatory postsynaptic 
currents (sEPSCs and mEPSCs) were recorded in voltage-clamp mode at a 
holding potential of -70 mV. Resting membrane potential was recorded in I=0 
mode, where no holding current was applied. Occasionally, spontaneous firing 
activity was seen in I=0, in which case the resting membrane potential was 
calculated by averaging regions where there was not firing activity. Spontaneous 
action potentials and current-voltage (I-V) curves were recorded in current-clamp 
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mode at resting membrane potential (i.e. I=0 pA). I-V curves were completed to 
measure GABAergic NTS neuron input resistance (Rin) and consisted of 6 current 
injections (-20 pA to +30 pA, 10 pA increments, 500 ms duration) with the resulting 
change in membrane potential being measured. Rin was calculated by plotting the 
linear portion of the I-V curve and calculating the slope. Series resistance was less 
than 25 M and monitored periodically throughout the recordings. If the series 
resistance changed by more than 20% over the course of the experiment, the 
recording was discarded. 
2.5 Drugs Used for Electrophysiological Recordings 
 The drugs and their respective concentrations used for experiments were: 
Tetrodotoxin (TTX; 1 M; Alomone Labs), 4-Aminopyridine (4-AP; 5 mM; Sigma-
Aldrich), (-)-Bicuculline Methiodide (BIC; 30 M; Tocris Biosciences), Kynurenic 
Acid (KYN; 1 mM; Sigma-Aldrich); Tetraethylammonium Chloride (TEA-Cl; 10 mM; 
Sigma-Aldrich). 
2.6 Statistical Analyses 
 For the survival study, a Kaplan-Meier survival curve was generated to 
assess mortality differences between control and pilo-SE mice. A log-rank (Mantel-
Cox) test was used to assess statistical significance. This is a nonparametric test 
used to compare the survival of two samples. Data analysis was performed using 
GraphPad Prism (La Jolla, CA). 
 Electrophysiology measurements included sEPSC frequency, sEPSC 
amplitude, mEPSC frequency, mEPSC amplitude, spontaneous action potential 
frequency (on-cell and whole-cell), paired-pulse ratio (PPr), frequency dependent 
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depression, spontaneous action potential half-width, A-type K+ current amplitude, 
sIPSC frequency, sIPSC amplitude, resting membrane potential and Rin. Analysis 
of electrophysiology measurements was performed using pClamp 10.2, 
MiniAnalysis (version 6.0.7, Synaptosoft; Decatur, GA) and GraphPad (La Jolla, 
CA) software programs. To measure sEPSC, mEPSC, whole and on-cell 
spontaneous action potential firing frequencies a 2-minute segment of continuous 
firing activity was used. For sEPSCs and mEPSCs only events with five times the 
root mean squared baseline noise were included. Events characterized by a fast 
rise phase and exponential decay were automatically detected and then manually 
verified by MiniAnalysis. An unpaired t-test was used to compare on and whole-
cell action potential frequency, sEPSC frequency, sEPSC amplitude, mEPSC 
frequency, mEPSC amplitude, PPr, frequency dependent depression, and action 
potential half-width between control and pilo-SE mice. A two-way ANOVA with a 
Sidak’s post hoc was used to compare the peak transient outward K+ current at 
each voltage step between control and pilo-SE mice in normal ACSF and before 
and after the application of 4-AP. A 2-way ANOVA (Tukey’s post hoc) was done to 
test for differences in the voltage dependence of activation and inactivation 
between control and pilo-SE mice. A 2-way ANOVA (Tukey’s post hoc) was 
completed to assess differences in steady state values between control and pilo-
SE mice. All data are presented as mean  SEM and statistical significance was 
set at p < 0.05.  
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Chapter 3 Functional neuroplasticity in the nucleus tractus solitarius and 
increased risk of sudden unexpected death in mice with acquired temporal 
lobe epilepsy 
This chapter was published in eNeuro, Sept/Oct. 2017; 4(5). Brian P. Delisle and 
Bret N. Smith are additional authors for this paper and this chapter is similar to the 
published manuscript.  
3.1 Introduction 
 Sudden unexpected death in epilepsy (SUDEP) occurs when an individual 
with epilepsy who is otherwise healthy dies suddenly for unknown reasons 
(Annegers, 1997; Nashef, 1997; Nashef et al., 2012; Tolstykh and Cavazos, 2013). 
For epilepsy patients, the risk of sudden unexpected death is >20-fold  higher than 
in the general population and accounts for ~17% of epilepsy-related deaths 
(Nashef, 1997; Kalume et al., 2013; Tolstykh and Cavazos, 2013), so it is 
imperative to elucidate its underlying mechanisms. Patients with longstanding 
epilepsy characterized by frequent generalized tonic-clonic seizures that are 
relatively poorly controlled are at highest risk (Tolstykh and Cavazos, 2013; 
Thurman et al., 2014). Patients with TLE represent ~60% of all epilepsies, and 
seizures are medically intractable in about 30% of these patients, making this the 
largest population at risk of SUDEP, yet mechanisms underlying increased SUDEP 
risk have not been identified in animal models of acquired TLE. Peri-ictal, centrally 
originating or peripheral autonomic irregularities leading to cardiorespiratory 
collapse may be the immediate cause of death in SUDEP (Ryvlin et al., 2013), but 
few studies have been aimed at identifying mechanisms of autonomic failure. 
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Seizures can increase activity of neurons in brainstem autonomic areas, 
independently of physical activity or peripheral metabolic influences (Kanter et al., 
1995; Takakura et al., 2011) and autonomic irregularities often develop over time 
in individuals with epilepsy, implicating central or peripheral autonomic reactive 
neuroplasticity as a potential driver of increased SUDEP risk in patients and rodent 
epilepsy models (Glasscock et al., 2010; Massey et al., 2014; Biet et al., 2015). 
Thus, recurrent seizures might induce changes in central or system physiologic 
functions that increase the risk for sudden death.  
 The brainstem vagal complex is the principal neural center mediating 
parasympathetic visceral regulation. Within the vagal complex, neurons of the 
nucleus tractus solitarius (NTS) receive viscerosensory information via vagal 
afferents and project their axons to preganglionic parasympathetic motor neurons 
in the dorsal motor nucleus of the vagus (DMV) and the nucleus ambiguus (NA; 
(Andresen and Kunze, 1994; Doyle and Andresen, 2001; Wang et al., 2001a; 
Wang et al., 2001b; Davis et al., 2004; Travagli et al., 2006; Glatzer et al., 2007; 
Bailey et al., 2008) as well as to brainstem and hypothalamic areas responsible for 
premotor sympathetic regulation and respiratory reflexes (Takenaka et al., 1995; 
Fontes et al., 2001; Irnaten et al., 2001; Bonham et al., 2006; Affleck et al., 2012; 
Zoccal et al., 2014). Inhibitory GABAergic NTS neurons participate in vagal 
reflexes and prominently regulate parasympathetic output (Davis et al., 2004; 
Travagli et al., 2006). Evidence from genetic epilepsy models suggests that 
epilepsy-related alterations in peripheral or central vagal function contribute to 
cardiorespiratory collapse and SUDEP (Glasscock et al., 2010; Cheah et al., 2012; 
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Glasscock et al., 2012; Kalume et al., 2013; Aiba and Noebels, 2015). Central 
vagal circuit plasticity is prominent in disease states that affect autonomic 
homeostasis (Mei et al., 2003; Bach et al., 2015; Bhagat et al., 2015; Boychuk et 
al., 2015a) and seizure-related derangement of central vagal system function has 
been briefly described, manifesting as increased likelihood of spreading 
depolarization in the NTS (Aiba and Noebels, 2015). Reactive neuroplasticity in 
the central vagal complex, however, has not been investigated in animals with 
acquired TLE. 
 We used the pilocarpine-induced status epilepticus (pilo-SE) model of TLE 
in mice (Shibley and Smith, 2002; Borges et al., 2003; Winokur et al., 2004; 
Groticke et al., 2007; Bhaskaran and Smith, 2010a; Bhaskaran and Smith, 2010b; 
Hunt et al., 2013) to identify long-term changes in NTS neuron function coinciding 
with the development of TLE. Because the NTS is the primary integration center 
for cardiorespiratory reflexes, and GABA neurons in particular are principal 
participants in vagal reflex activity (Glatzer et al., 2007; Bailey et al., 2008) 
increased excitability of these neurons would be consistent with an increased 
propensity for central autonomic failure that could lead to SUDEP in TLE. We 
tested the hypothesis that reactive plasticity of GABAergic circuitry in the NTS 
emerges over time in mice that survive pilocarpine-induced SE. 
3.2 Methods 
3.2.1 ECG Telemetry 
 Mice were anesthetized with 2.5% isofluorane in 100% O2 at 1.5 L/min and 
2-inch midline incision was made through the skin of the abdomen exposing the 
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fascia. Hemostats were used to separate the fascia from the skin and create space 
for the ECG leads underneath the skin. The telemeter body (model ETA-F10; Data 
Sciences International, St.Paul, MN) was implanted on the right flank with the 
positive lead near the right pectoral muscle and the negative lead on the left side 
of the abdomen. The leads were secured by being embedded in the fascia 
underneath the skin. The incision was closed with staples (autoclips, Kent 
Scientific Corporation, Torrington, CT) and allowed to heal for two weeks prior to 
use.  
 Telemeters were turned on at least 24 hours prior to recordings in order to 
minimize disturbances and stress to the mice. Data were recorded for 24 hours 
pre-injection of vehicle or pilocarpine, 24 hours after injection and at 6 and 12 
weeks after injection. ECG data were collected with DSI DataQuest A.R.T. 4.31 
and Ponemah 6.10 and analyzed with Ponemah 6.10 telemetry software.  Data 
were acquired at a sampling rate of 1000 Hz, which is the standard rate used for 
mice and results in a smooth physiologic signal when the ECG waveforms are 
graphed; the telemetry device used a factory preset sampling rate of 200 Hz. No 
low-pass or high-pass filtering was applied during data acquisition. For ECG 
waveform analysis, the software was set to use a 40% QRS detection threshold 
(percentage of the largest derivative peak in QRS segment resulting in an R that 
satisfies the minimum heart rate criteria), a minimum of R deflection of 0.25 mV, a 
maximum heart rate of 1000 bpm, and a minimum heart rate of 80 bpm.  
 Average heart rate was calculated from data from 1 hour recording periods, 
as described previously (Metcalf et al., 2009a; Ho et al., 2011; Schroder et al., 
 48 
2015); all recordings were performed during seizure-free periods. The RR interval 
was manually examined and filtered for abnormal beats by sorting the RR interval 
from shortest to longest and deleting cycles that were two standard deviations from 
the average RR interval, and the ECG channel was subsequently reanalyzed by 
setting upper and lower limits on RR values (Thireau et al., 2008). Areas of the 
recording that contained skipped beats or loss of signal were also deleted. The 
remaining cycles were then averaged to comprise the NN (i.e. RR) interval, which 
was then used to calculate the standard deviation of the N-to-N interval (SDNN) 
and the root mean squared of the standard deviation of the RR interval (RMSSD). 
The SDNN was calculated by taking the square root of the averaged NN interval. 
The RMSSD was calculated with the following steps: (1) the difference between 
the NN interval and delayed NN interval was squared; (2) the squared difference 
was summed; (3) the number of NN intervals was counted; and (4) the sum of the 
difference squared was divided by the count of NN intervals. RMSSD is reported 
as the square root of this value.  
3.2.2 Electrophysiological Stimulation 
 Electrical stimulation was performed using a platinum-iridium concentric 
bipolar electrode (125 m diameter, FHC, Bowdoinham, ME) that was placed in 
the solitary tract (ST) (Glatzer and Smith, 2005; Glatzer et al., 2007). Sets of 5 
current pulses (30-50 A; 400 s) were delivered at interpulse intervals of 30 ms 
at 50 Hz to the ST and responses in NTS neurons voltage-clamped at -70 mV were 
recorded and the constant latency and amplitude evoked EPSC (eEPSC) 
responses were measured. The stimulus intensity was adjusted so that eEPSCs 
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occurred > 80% of the time in GABAergic NTS neurons when stimulation was 
applied to the ST. Thirty stimulation sweeps were applied to each cell and 
averaged for further assessment. The ratio of the second to the first eEPSC (i.e. 
paired-pulse ratio, PPr) was measured in order to infer changes in the probability 
of excitatory neurotransmitter release. An increase in the release ratio typically 
correlates with a decrease in the probability of presynaptic neurotransmitter 
release, in this case presynaptic input arising from the ST (Schild et al., 1995; 
Zucker and Regehr, 2002; Pamidimukkala and Hay, 2004; Chen and Bonham, 
2005; Glatzer and Smith, 2005; Glatzer et al., 2007; Laaris and Weinreich, 2007). 
Frequency-dependent depression (FFD) is a common characteristic of second-
order NTS neurons that receive input from the ST (Miles, 1986; Doyle and 
Andresen, 2001; Bailey et al., 2008; Kline, 2008). In order to assess the FDD, the 
ratio of the amplitudes of the 5th eEPSC to the 1st eEPSC are measured.  Stimulus 
sweeps were only included if an eEPSC was elicited after each stimulation in that 
sweep and the constant latency was less than 0.2 ms to ensure that responses to 
stimulation were monosynaptic in nature (Glatzer et al., 2007; Bailey et al., 2008). 
 Methods for Chapter 3 also included: methylscopolamine and pilocarpine 
injections, seizure assessment, and on- and whole-cell patch-clamp 
electrophysiology as described in Chapter 2 of this dissertation.  
3.3 Results 
3.3.1 Pilocarpine-induced SE as a model of SUDEP  
 Spontaneous seizure activity was monitored in a cohort of mice (n=6 control 
mice; n=6 pilo-SE mice) for 1 week between 11 and 12 weeks post-SE. Similar to 
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previous reports (Shibley and Smith, 2002; Winokur et al., 2004; Hunt et al., 2013) 
spontaneous seizures were observed during this period in 83% (5 of 6) pilocarpine-
treated mice that survived SE. A separate cohort of mice were monitored for long-
term survival after pilocarpine-induced SE. Similar to previous reports (Shibley and 
Smith, 2002; Winokur et al., 2004), all vehicle-injected mice survived the duration 
of the monitoring period of 150 days (100%; n=10 mice). Between 1 and 7 days 
after pilocarpine-induced SE, there was a 13.33% mortality rate (2/15 mice). These 
mice were not considered to have died of SUDEP, as epilepsy (i.e. with 
spontaneous seizures) likely had not developed by this time. Of the 13 pilocarpine-
treated mice that survived for greater than 7 days post-SE, only 3 mice (23%) 
survived to 150 days post-treatment, with no obvious trauma or other incident; 60% 
died after greater than 40 days post-SE (Fig. 3.1). Thus, the survival rate of mice 
that survived pilo-SE was significantly decreased at 150 days compared to with 
vehicle-treated control mice (log-rank Mantel-Cox; p = 0.0002).  
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Figure 3.1 Pilocarpine-induced SE (pilo-SE) increases the risk of sudden death. 
Pilocarpine-treated mice (Pilo-SE; n=15) have a decreased survival rate (23%) 
compared to control mice (n=10, 100%; Log-rank Mantel-Cox; p = 0.0002). Mice 
that survived SE died suddenly and unexpectedly at post-SE time points 
associated with the development of spontaneous seizures. 
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3.3.2 Increased action potential firing in GABAergic NTS neurons from 
pilo-SE mice is glutamate receptor dependent 
 Seizure-induced depolarization in the NTS of mice with genetic epilepsies 
originates in the lateral NTS (Aiba and Noebels, 2015), and area densely 
comprised of GABAergic neurons (Blessing, 1990; Fong et al., 2005; Glatzer et 
al., 2007). We hypothesized that GABAergic NTS neurons, most of which receive 
primary viscerosensory input from the vagus nerve (Glatzer et al., 2007; Bailey et 
al., 2008), are altered functionally post-SE. On-cell recordings of GABAergic NTS 
neurons were performed to determine whether spontaneous action potential firing 
differed between control and pilo-SE mice (Fig. 3.2A,B,E). One week post-
treatment, GABAergic NTS neurons from seven pilo-SE mice displayed 
significantly higher action potential firing frequency (3.35 ± 0.46 Hz; n=20 cells) 
compared with NTS GABAergic neurons from seven age-matched control mice 
(1.32 ± 0.30 Hz; n=15 cells; p = 0.002). Spontaneous action potential firing in 
GABAergic NTS neurons was also significantly increased 6 weeks after treatment 
in five pilo-SE mice (3.32 ± 0.65 Hz; n=16 cells) compared with eight age-matched 
control mice (2.10 ± 0.25 Hz; n=26 cells; p = 0.046). Similarly, action potential firing 
frequency remained significantly greater in GABAergic NTS neurons from seven 
age-matched pilo-SE (4.27 ± 0.96 Hz; n=24 cells) than seven age-matched control 
mice (2.21 ± 0.27 Hz, n=23 cells; p = 0.0048) 12 weeks post-treatment (Fig.3.2E). 
Therefore, action potential frequency was consistently higher in GABAergic NTS 
neurons in mice that survived SE than in control mice. 
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 To determine whether the increase in firing frequency was due to increased 
activation of ionotropic glutamate receptors, spontaneous action potential firing 
was recorded in the presence of the ionotropic glutamate receptor antagonist, 
kynurenic acid (KYN; 1mM; Fig.3.2C,D,F). In the presence of KYN, the action 
potential firing frequency in GABAergic NTS neurons from pilo-SE mice was similar 
to that of control mice 1, 6, and 12 weeks post-treatment (week 1: p = 0.47; week 
6: p = 0.83; week 12: p = 0.78; Fig.3.2F). Therefore, increased action potential 
firing in GABAergic NTS neurons from mice that survived SE depended on 
activation of ionotropic glutamate receptors, implicating increased glutamate-
mediated, excitatory synaptic drive to these neurons during epileptogenesis.  
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Figure 3.2 Action potential frequency in GABAergic nucleus tractus solitarius 
(NTS) neurons from pilo-SE mice is dependent on glutamate receptor activation. 
A) Representative traces showing action potential firing (Na+ currents) in 
GABAergic NTS neurons in slices from control mice recorded in normal ACSF 
(nACSF) at three different time points (i.e., 1, 6, and 12 weeks) after vehicle 
treatment. (B) Representative traces showing action potential firing in GABAergic 
NTS neurons from mice that survived pilo-SE under normal recording conditions 
(nACSF) at three different time points after SE. (C) Representative traces of action 
potential firing in control mice in the presence of kynurenic acid (KYN; 1mM) at 
these same time points. (D) Representative traces of action potential firing in the 
presence of KYN in pilo-SE mice. (E) Action potential firing frequency is 
significantly greater in pilo-SE mice compared to age-matched control mice at 1, 
6, and 12 weeks post-treatment (unpaired t-test; *denotes significance at p<0.05). 
(F) In the presence of KYN, action potential firing frequency in NTS GABA neurons 
from pilo-SE mice was not significantly different than in control mice (unpaired t-
test; p>0.05).  
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3.3.3 GABAergic NTS neurons display increased excitatory regulation 
 An increase in spontaneous action potential firing in GABAergic NTS 
neurons from pilo-SE mice could occur because of altered intrinsic and/or synaptic 
properties. To determine whether intrinsic properties were altered post-SE, we 
measured the resting membrane potential and input resistance in GABAergic NTS 
neurons and found that there were no significant differences between control and 
pilo-SE mice at any time point (Table 3.1). Because firing rate differences were 
abrogated by KYN, we hypothesized that excitatory glutamatergic synaptic input 
was increased after pilo-SE. To test this hypothesis, whole-cell patch-clamp 
recordings were used to examine the frequency and amplitude of spontaneous and 
miniature EPSCs in GABAergic NTS neurons from age-matched control and pilo-
SE mice (Fig 3.3). One week post-treatment, sEPSC frequency in GABAergic NTS 
neurons from six pilo-SE mice (4.98 ± 0.98 Hz; 12 cells) was significantly greater 
than seven control mice (1.61 ± 0.40 Hz; n=10 cells; p = 0.007). The increased 
sEPSC frequency was also seen at 6 weeks post-SE (five control mice: 2.17 ± 
0.46 Hz; n=9 cells; seven pilo-SE mice: 3.40 ± 0.36 Hz; n=13 cells; p = 0.045) and 
12 weeks post-treatment in seven pilo-SE mice (2.57 ± 0.46 Hz; n=15 cells) 
compared with 11 age-matched control mice (1.55 ± 0.27 Hz; n=20 cells; p = 0.03; 
Fig3.3C). There was no significant difference in sEPSC amplitude at any time point 
post-treatment (week 1: p = 0.82; week 6: p = 0.89; week 12: p = 0.20; Fig3.3D). 
Therefore, glutamate release onto NTS GABAergic neurons was increased after 
pilo-SE, and this increased release period persisted for at least 3 months post-SE. 
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Table 3.1 Resting Membrane Potential and Input Resistance.  
Resting membrane potential (RMP) and input resistance of GABAergic NTS 
neurons in mice that survived SE is not significantly different from age-matched 
control mice at any time point (unpaired t-test; p > 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Input Resistance (MΩ) 
Resting Membrane Potential 
(mV) 
  Control Pilo-SE Control Pilo-SE 
Week 1 1160 ± 600 1590 ± 490 -47.65 ± 5.35 -51.69 ± 4.25 
Week 6 1369 ± 346 1180 ± 293 -52.23 ± 3.69 -53.32 ± 3.63 
Week 12 2477 ± 611 1905 ± 429 -55.93 ± 3.31 -57.57 ± 3.33 
 57 
 
 
 
Figure 3.3 Significantly increased sEPSC frequency in GABAergic NTS neurons 
from pilo-SE mice.  
(A) Representative traces showing sEPSCs in a GABAergic NTS neuron from 
control mice 1, 6, and 12 weeks post-treatment. (B) Representative traces showing 
sEPSCs in a GABAergic NTS neuron from pilo-SE mice 1, 6, and 12 weeks post-
treatment. (C) sEPSC frequency is significantly higher in GABAergic NTS neurons 
from pilo-SE mice compared to control mice 1, 6, and 12 weeks post-treatment 
(unpaired t-test; *denotes significance). (D) sEPSC amplitude is not significantly 
different (unpaired t-test; p>0.05) between control and pilo-SE mice at any time 
point. 
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The hypothesis that the increased release of glutamate depended on action 
potentials in afferent neurons within the slice was tested by measuring the 
frequency and amplitude of mEPSCs in the presence of tetrodotoxin (TTX, 1 µM), 
which was added to ACSF to block Na+ channels and prevent action potential firing 
(Fig.3.4). Unlike for sEPSCs at 1 week post-treatment, mEPSC frequency was not 
significantly increased in five pilo-SE mice (2.37 ± 0.35 Hz; n=9 cells) compared 
with three control mice (1.88 ± 0.34 Hz; n=8 cells; p = 0.33). Miniature EPSC 
frequency was significantly increased, however in GABAergic NTS neurons at 6 
weeks (five control mice: 1.36 ± 0.24 Hz; n=15 cells; six pilo-SE mice: 3.10 ± 0.47 
Hz; n=13 cells; p = 0.003) and 12 weeks (five control mice: 1.46 ± 0.13 Hz; n=15 
cells; seven pilo-SE mice: 2.52 ± 0.38 Hz; n=12 cells; p = 0.007; Fig 3.4C). 
Miniature EPSC amplitude in GABAergic NTS neurons from control and pilo-SE 
mice was not significantly different at any time point post-treatment (week 1, p = 
0.85; week 6, p = 0.18; week 12, p =.10; Fig 3.4D). Therefore, glutamate release 
was increased in GABAergic NTS neurons after pilo-SE, and the increase detected 
after 6 weeks did not depend on action potential firing in glutamatergic neurons 
contained within the slice preparation, suggesting that changes at the level of the 
synaptic terminals contributed to the development of altered glutamate release in 
the NTS during epileptogenesis.  
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Figure 3.4 Significantly increased mEPSC frequency in GABAergic NTS neurons 
from pilo-SE mice.  
(A) Representative traces showing mEPSCs in a GABAergic NTS neuron from a 
control mouse 1, 6, and 12 weeks post-treatment. (B) Representative traces 
showing mEPSCs in a GABAergic NTS neuron from a pilo-SE mouse 1, 6, and 12 
weeks post-treatment. (C) mEPSC frequency is significantly higher in GABAergic 
NTS neurons from pilo-SE mice compared to control mice at 6 and 12 weeks post-
treatment (unpaired t-test; *denotes significance at p<0.05). (D) mEPSC amplitude 
is not significantly different between control and pilo-SE mice at any time point 
(unpaired t-test). 
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3.3.4 Primary vagal afferent input to GABAergic NTS neurons was not 
altered in pilo-SE mice 
 The increase in mEPSC frequency in GABAergic NTS neurons from pilo-
SE mice suggests an increase in the probability of presynaptic glutamate release, 
possibly including from vagal afferent terminals. Nerve terminals of viscerosensory 
primary vagal afferents synapse directly onto second order sensory NTS neurons, 
including GABAergic neurons, the majority of which receive primary vagal input 
(Glatzer et al., 2007; Bailey et al., 2008). Synaptic responses evoked after 
stimulating vagal afferents exhibit paired-pulse inhibition and frequency-dependent 
depression (Miles, 1986; Doyle and Andresen, 2001; Glatzer and Smith, 2005; 
Bailey et al., 2008). We therefore tested the hypothesis that glutamate release from 
primary vagal afferents was enhanced in pilo-SE mice by measuring synaptic 
responses to stimulation of the ST in GABAergic NTS neurons. Examples of 
responses in NTS GABA neurons to repetitive stimulation of the ST in each group 
are shown in Fig 3.5. One week post-treatment, the PPr was not significantly 
different between three control mice (0.71 ± 0.07; n=8 cells) and three pilo-SE mice 
(0.87 ± 0.10; n=8 cells; p = 0.27). At 6 weeks post-treatment, the PPr was not 
significantly altered in four pilo-SE mice (1.02 ± 0.13; n=8 cells) compared with five 
control mice (0.75 ± 0.14; n=5 cells; p = 0.16). There was also no significant 
difference in the PPr at 12 weeks post-treatment between five control mice (0.71 
± 0.06; n=11 cells) and six pilo-SE mice (0.82 ± 0.06; n=14 cells; p = 0.12; Fig 
3.5D). Thus, the increased glutamate release in GABAergic NTS neurons that 
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developed after pilo-SE was likely not due to modification of synaptic release 
probability in vagal afferents. 
 Although changes in the PPr after SE survival are an indicator of alterations 
in the releasable vesicle pool (Schild et al., 1995; Zucker and Regehr, 2002; 
Pamidimukkala and Hay, 2004), frequency-dependent depression provides insight 
into synaptic communication between the vagal afferent fibers and GABAergic 
NTS neurons that may rely on additional mechanisms (Chen et al., 1999; Atwood 
and Karunanithi, 2002; Kline, 2008; Zhao et al., 2015). Frequency-dependent 
depression is a common characteristic of second-order NTS neurons receiving 
viscerosensory afferent input and has been hypothesized to contribute to central 
adaptation during cardiovascular and respiratory reflexes (Miles, 1986; Doyle and 
Andresen, 2001; Kline et al., 2005; Glatzer et al., 2007; Bailey et al., 2008; Kline, 
2008). 
 We also tested the hypothesis that frequency-dependent depression was 
altered in mice that survived SE by analyzing the amplitude ratios of the 5th to the 
1st eEPSC in a train (Fig 3.5F). Similar to the PPr analysis, there was no significant 
difference between three control mice 1 week (0.55 ± 0.09; n=8 cells) and three 
pilo-SE mice (0.56 ± 0.08; n=8 cells; p = 0.89), 6 weeks (control: 0.52 ± 0.08; n-=5 
cells; pilo-SE: 0.78 ± 0.12; n=8 cells; p = 0.14), or 12 weeks post-treatment (control: 
0.56 ± 0.07; n=11 cells; pilo-SE: 0.71 ± 0.07; n=14 cells; p = 0.31; Fig3.5F). These 
data are consistent with the hypothesis that release properties at vagal afferent 
synapses with GABAergic NTS neurons are not altered after pilo-SE. 
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Figure 3.5 Paired pulse ratio (PPr) and frequency dependent depression are 
transiently altered in pilo-SE mice.  
(A) Representative traces of eEPSC responses in GABAergic NTS neurons 1 
week post-treatment from control and pilo-SE mice. (B) Representative traces of 
eEPSC responses in GABAergic NTS neurons 6 weeks post-treatment from 
control and pilo-SE mice. (C) Representative traces of eEPSC responses in 
GABAergic NTS neurons 12 weeks post-treatment from control and pilo-SE mice. 
(D) The PPr was not significantly different between control and pilo-SE mice at any 
time point post-treatment (unpaired t-test; p>0.05). (E) The ratio of the 5th response 
amplitude to that of the 1st response was also not significantly altered in pilo-SE 
mice at any time point (unpaired t-test; p>0.05). 
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3.3.5 Heart rate and heart rate variability in mice surviving SE is not 
altered long-term 
 In chemoconvulsant-induced SE models of acquired TLE in rats, changes 
in cardiac rhythmicity that may reflect plasticity of either central or peripheral vagal 
regulatory function or cardiac remodeling are detected coincident with 
epileptogenesis (Metcalf et al., 2009b; Bealer et al., 2010; Biet et al., 2015). We 
examined mouse ECG activity for changes in heart rate and HRV over time to 
assess whether ongoing cardiac rhythms were altered following SE. Table 3.2 
describes heart rate and two measures of HRV in six control mice and eight 
pilocarpine-treated mice that survived SE. Heart rate was significantly increased 
in mice that survived SE compared with their heart rate 24 hours before treatment 
(baseline, 525.8 ± 22.02 bpm; post-SE, 636.1 ± 39.12 bpm; n=8 mice; p = 0.018). 
This was also true for the SDNN, a measure of HRV. The SDNN was significantly 
decreased 24 hours post-SE (baseline, 10.77 ± 0.21 ms; post-treatment, 9.85 ± 
0.34 ms; p= 0.038). No significant differences were detected at any other time 
points after SE induction in these same mice, nor were any differences detected 
over the 12-week recording period in the RMSSD (two-way ANOVA; F 
(3,46)=0.135; p = 0.939, Table 3.2). 
 
 
 
 
 
 64 
Table 3.2 Heat rate and heart rate variability (HRV) in mice that survived SE.  
Heart rate and the standard deviation of the N-to-N interval (SDNN) were 
increased 24 hours after SE, but no differences were detected at other time points 
(Heart Rate: Two-Way ANOVA, F(3,46) = 2.52, p = .069; SDNN: Two-Way 
ANOVA, F (3,46) = 2.25, p = 0.094). The root mean squared of the standard 
deviation (RMSSD) was not significantly different at any time point (Two-Way 
ANOVA, F (3,46) = 0.135, p = 0.939). 
 
  Control (n=6) Pilo-SE (n=8) 
  
Heart Rate 
(bpm) 
SDNN 
(ms) 
RMSSD 
(ms) 
Heart Rate 
(bpm) 
SDNN 
(ms) 
RMSSD 
(ms) 
Baseline 
539.42 ±  
14.23 
10.60 ± 
0.13 
2.96 ± 
0.65 
525.8 ±  
22.02 
10.77 ± 
0.21 
3.22 ± 
0.38 
24 h 
534.66 ±  
8.92 
10.68 ± 
0.08 
3.37 ± 
0.51 
636.10 ± 
39.12 
9.85 ±  
0.34 
2.86 ± 
0.59 
Week 6 
549.96 ±  
12.93 
10.48 ± 
0.13 
3.21 ± 
1.25 
556.90 ± 
26.26 
10.47 ± 
0.23 
3.32 ± 
0.45 
Week 12 
530.54 ±  
9.28 
10.68 ± 
0.09 
3.12 ± 
0.66 
524.10 ± 
18.19 
10.75 ± 
0.19 
3.27 ± 
0.62 
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3.4 Discussion 
 The present study investigated survival rates and changes in GABAergic 
NTS neuron function in mice that survived pilo-SE. Mice that died within 1 week of 
SE were considered to have failed to recover from SE and therefore not to have 
died of SUDEP, since they likely did not have epilepsy. Of the mice that survived 
the first week after pilocarpine-induced SE, just 23% survived to 150 days post-
SE, whereas 100% of control mice survived the duration of the study. Patients with 
longstanding epilepsy characterized by frequent generalized tonic-clonic seizures 
that are relatively poorly controlled are at highest risk for SUDEP (Surges and 
Sander, 2012; Tolstykh and Cavazos, 2013; Massey et al., 2014; Thurman et al., 
2014; Dlouhy et al., 2016). SUDEP risk in patient populations with relatively rare 
genetic epilepsies such as Dravet’s syndrome, which accounts for about 3% of 
patients with epilepsy, is high (Wu et al., 2015), and many studies have been aimed 
at elucidating the causes of SUDEP in genetic epilepsies. Patients with TLE 
represent ~60% of all epilepsies, however, and seizures are medically intractable 
in about one-third of TLE patients, making this the largest epilepsy population at 
risk of SUDEP. The pilocarpine-induced SE model in mice represents a consistent 
and highly replicable TLE model in which mice develop spontaneous seizures 
within a few weeks after recovery from SE (Shibley and Smith, 2002; Winokur et 
al., 2004; Scorza et al., 2009; Bhaskaran and Smith, 2010b), promoting this mouse 
as a reasonable model of SUDEP in TLE. Pilocarpine plasma and brain levels peak 
in the minutes after injection and fall to almost zero by 2 hours post-injection; it is 
therefore doubtful that the single exposure to pilocarpine itself is responsible for 
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our findings, which were measured days to months after injection (Romermann et 
al., 2015). Additionally, microinjection of muscarinic receptor agonists in the NTS 
alters function for 4-6 minutes after application without sustained changes 
(Sundaram et al., 1988). Thus, decreased survivability and increased NTS circuit 
excitability likely develop coincident with epileptogenesis in this model, rather than 
as a result of a brief exposure to the muscarinic agonist.  
 Sudden unexpected death has been documented in mouse models of 
genetic epilepsy (Goldman et al., 2009; Glasscock et al., 2010; Cheah et al., 2012; 
Aiba and Noebels, 2015) and unexpected death has been noted anecdotally in 
models of acquired TLE. In murine Kv1.1-null and Dravet’s syndrome genetic 
epilepsy models, mice begin having seizures by approximately the third week of 
life, and most animals do not survive past day 90 (Cheah et al., 2012). These 
models use genetically mediated ion channel derangement to induce epilepsy, and 
the channelopathies themselves could increase the likelihood of sudden death. 
They can also result in altered electrical properties of cardiomyocytes, 
complicating interpretations of the contribution of the effects of seizures-versus the 
channelopathy itself to death (Auerbach et al., 2013). Conversely, seizures in the 
pilocarpine-SE model induce reactive neuroplasticity, including ion channel and 
synaptic reorganization in cortical structures (Shibley and Smith, 2002; Su et al., 
2008; Metcalf et al., 2009b; Bealer et al., 2010; Guo et al., 2013), and the present 
results indicate they also induce remodeling in brainstem neurons or circuits, which 
could contribute to central autonomic dysregulation. After the initial post-SE period, 
heart rate and HRV were not affected in this mouse model, but cardiac arrhythmias 
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have been detected in rats with acquired epilepsy (Powell et al., 2014). An increase 
in baseline heart rate that coincided with sympathovagal imbalance has been 
described in rats 2 weeks after pilocarpine injection, before the development of 
spontaneous seizures (Metcalf et al., 2009a; Bealer et al., 2010). Although similar 
changes were not detected in the mouse model of TLE used here, further work is 
necessary to determine whether seizure-related peripheral changes in 
cardiorespiratory function accompany epileptogenesis in mice, perhaps using 
isolated hearts to limit the influence of central autonomic regulatory mechanisms 
(Powell et al., 2014). Our results are consistent with the hypothesis that central 
autonomic plasticity develops during epileptogenesis in mice, regardless of any 
potential for cardiac remodeling. Given the critical importance of the vagal complex 
in regulating cardiac and respiratory reflex function, the development of increased 
excitability in the NTS during epileptogenesis could reasonably be predicted to 
increase the propensity for SUDEP in pilocarpine-treated mice. 
 The vagal complex in the caudal brainstem controls autonomic output to the 
thoracic and most abdominal viscera. Within the vagal complex, GABAergic 
neurons in the NTS receive, filter, and integrate viscerosensory information 
regarding cardiorespiratory function and modulate both vagal and sympathetic 
tone. Neuroplasticity in the vagal complex occurs in a variety of diseases (Mei et 
al., 2003; Zsombok and Smith, 2009; Bach et al., 2015) and these neurons also 
displayed functional changes weeks to months after SE. GABAergic neurons 
displayed significantly and chronically increased spontaneous action potential 
firing after SE. Significant differences in the passive membrane properties of 
 68 
GABAergic NTs neurons in pilo-SE mice were not detected, but the increase in 
excitability was accompanied by increased glutamate release, evidence by 
significantly higher sEPSC and mEPSC frequency versus age-matched controls. 
Notably, age-related increases in NTS neuron excitability have been documented 
(Johnson and Felder, 1993), so all comparisons here were made between age-
matched groups. The increased activity was eliminated when ionotropic glutamate 
receptors were blocked, providing further evidence that long-term changes in 
synaptic function are associated with epileptogenesis in this model. 
 The increased glutamate release shortly after pilo-SE was action potential 
dependent, suggesting an initial increase in excitability of local interneurons. Action 
potential-independent release, however, was significantly increased by 6 weeks, 
suggesting the development of altered presynaptic release properties or formation 
of new synapses in the NTS during epileptogenesis. Most GABAergic NTS 
neurons receive direct vagal input (Glatzer et al., 2007; Bailey et al., 2008) 
evidenced by eEPSCs with constant response latency (i.e. synaptic jitter <0.2 ms) 
after ST stimulation. Reduced expression of K+ channels in the vagus nerve of 
Kv1.1-null mice with epilepsy has been reported (Goldman et al., 2009; Glasscock 
et al., 2010; Glasscock et al., 2012), and seizure-induced K+ channel remodeling 
in vagal or other afferents could contribute to the increase in glutamate release 
onto the GABAergic NTS neurons in pilocarpine-treated mice. However, changes 
in synaptic release properties of vagal afferent terminals were not detected. In 
addition to synaptic vagal afferent input, these receive glutamatergic synapses 
originating from local NTS neurons and from other brain areas (Nishimura and 
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Oomura, 1987; Zhang et al., 1999; Glatzer et al., 2007), consistent with the 
hypothesis that synaptic reorganization of central neurons contributes to the 
increased glutamate release in the NTS during epileptogenesis. 
 The cellular mechanisms underlying the increased glutamate release and 
enhanced excitability of NTS GABA neurons have yet to be elucidated, but the 
increase in synaptic excitation is reminiscent of the synaptic rearrangement that 
occurs in cortical inhibitory interneurons during epileptogenesis (Hunt et al., 2011; 
Zhang et al., 2011) and is consistent with dysregulation of autonomic control of the 
thoracic and abdominal viscera. Increased synaptic excitation of GABAergic NTS 
neurons would be expected to inhibit parasympathetic motor output and suppress 
autonomic reflex responses in pilo-SE mice. Because NTS neurons also project to 
neurons that inhibit medullary synaptic circuits (Card et al., 2006), increased 
activity might also chronically disinhibit sympathetic motor output. Respiratory 
centers receiving input from NTS neurons with altered excitability may also be 
affected (Stornetta and Guyenet, 1999).  
 The chronic increase in glutamate-mediated cellular excitability after SE 
may also make GABAergic NTS neurons more susceptible to sodium channel 
inactivation in the event of excessive depolarization, as can occur if seizures 
spread to this brainstem area (Aiba and Noebels, 2015). Spreading depression 
and depolarization block have been well studied in cortical neurons and implicated 
in the pathophysiology of migraine and stroke (Dreier and Reiffurth, 2015; Dreier 
et al., 2015). NTS neurons are normally resistant to spreading depression 
(Somjen, 2001; Dreier and Reiffurth, 2015), but focal cortical seizures in mice with 
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epilepsy induced spreading depolarization in the NTS under conditions of 
metabolic deprivation, which was followed by cardiorespiratory collapse and 
sudden death in genetic epilepsy models (Aiba and Noebels, 2015). Spreading 
depression is typically initiated in the lateral NTS, an area of the nucleus that 
receives inspiratory vagal afferent input from the lung (Donnelly et al., 1989) and 
is enriched in GABAergic neurons (Blessing, 1990; Fong et al., 2005; Glatzer et 
al., 2007). The elevated synaptic excitability in GABAergic NTS neurons in mice 
that survived pilocarpine-induced SE is consistent with an increased propensity for 
depolarization block and action potential inactivation in these neurons, which could 
increase the likelihood that depolarization block and spreading depression could 
evolve in the NTS (Haller et al., 2001; Larrosa et al., 2006; Sawant-Pokam et al., 
2017). Whereas cortical seizures that spread to the NTS can evoke spreading 
depolarization associated with SUDEP, other coordinated input to the nucleus, 
such as that which occurs during vagal reflex initiation, might also render the region 
susceptible to spreading depolarization in mice with TLE. GABAergic NTS neurons 
play a critical role as mediators of cardiac, respiratory, and baroreceptor reflexes 
(Andresen and Kunze, 1994; Kanter et al., 1995; Wang et al., 2001a; Wang et al., 
2001b; Zoccal et al., 2014). Because we did not see any cardiac-specific 
phenotypes in the mice with pilocarpine-induced TLE, we hypothesize that the 
increase in NTS neuron excitability leads to an increased propensity for 
depolarization block and spreading depression centrally, resulting in sudden death 
under specific conditions (Aiba and Noebels, 2015). Notably, this is not necessarily 
superimposed on chronic changes in cardiac function in this model. These central 
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mechanisms may lead to aberrant baroreceptor or cardiorespiratory reflexes in the 
pilo-SE mice, but intrinsic changes in cardiac function may not be expressed under 
nominal conditions.  
 The present results show that mice that survive SE are susceptible to 
SUDEP after several weeks. Our findings are consistent with the hypothesis that 
glutamate release is persistently elevated in the NTS after SE, evidenced by an 
increase in glutamatergic synaptic input to GABAergic NTS neurons and a 
corresponding increase in neuronal activity. Chronically increased activity in 
GABAergic NTS neurons would be expected to impact parasympathetic or 
sympathetic tone, autonomic reflexes, including cardiorespiratory reflexes, and 
may underlie seizure-induced depolarization block and spreading depression in 
the nucleus, leading to cardiorespiratory collapse and SUDEP. Our results also 
suggest multiple components contribute to the altered excitation of NTS GABA 
neurons, including an initial increase in glutamate release driven by action 
potentials in local neurons and a delayed, persistent increase in presynaptic 
glutamate release from synaptic terminals of central neurons. These changes likely 
involve seizure-induced synaptic or channel reorganization within the central vagal 
system. Although the mechanistic cause of SUDEP per se has been debated 
(Surges and Sander, 2012; Ryvlin et al., 2013; Aiba and Noebels, 2015), it is most 
likely not due to a single etiology such as cardiac changes, at least in mice with 
TLE. We posit that in TLE, SUDEP may result from multiple factors (e.g. cardiac 
or respiratory failure), and the triggers for these are superimposed on dysregulated 
NTS circuits. Understanding the cellular changes in the NTS that are associated 
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with seizures may prompt the development of predictive biomarkers for SUDEP in 
those populations most at risk, and eventually therapies to prevent SUDEP.  
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Chapter 4 Alterations in A-type current in the nucleus tractus solitarius in 
acquired temporal lobe epilepsy 
 
4.1 Introduction 
Approximately 60% of all individuals with epilepsy have temporal lobe 
epilepsy (TLE), which is characterized by recurrent, unprovoked electrical activity 
originating in the medial portions of the temporal lobe. In about 30% of these 
individuals, seizures are medically intractable. Sudden Unexpected Death in 
Epilepsy (SUDEP) is defined as when an individual who is otherwise healthy, dies 
suddenly and unexpectedly for unknown reasons and is one of the leading causes 
of death in individuals with epilepsy and risk is increased in patients with 
uncontrolled seizures (Annegers, 1997; Nashef, 1997; Nashef et al., 2012; 
Tolstykh and Cavazos, 2013; Ellis and Szabo, 2018). Previous studies in mouse 
models of genetic epilepsy have suggested that functional seizure-related that 
alterations in brainstem centers that modulate peripheral autonomic and 
cardiorespiratory reflexes are associated with an increased risk for SUDEP 
(Goldman et al., 2009; Glasscock et al., 2010; Cheah et al., 2012; Kalume et al., 
2013; Simeone et al., 2018). It has also been shown in mouse models of genetic 
epilepsy that seizures can spread from the cortex to the brainstem, leading to 
cardiorespiratory collapse and sudden death (Aiba and Noebels, 2015). 
Importantly, we have recently shown in a model of acquired TLE that -
aminobutyric acid (GABA) neurons in the nucleus tractus solitarius (NTS), the 
primary central autonomic integration area in the caudal brainstem, are 
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hyperexcitable in a mouse model of TLE, which may contribute to increased 
SUDEP risk in this model (Derera et al., 2017). 
The NTS is located in the dorsal vagal complex of the caudal brainstem and 
is the principal central locus of visceral autonomic integration. NTS neurons 
receive primary glutamatergic inputs from vagal afferent fibers and project their 
axons to preganglionic parasympathetic motor neurons in the dorsal motor nucleus 
of the vagus (DMV) and the nucleus ambiguus (NA) (Andresen and Kunze, 1994; 
Doyle and Andresen, 2001; Wang et al., 2001b; Davis et al., 2004; Travagli et al., 
2006; Glatzer et al., 2007; Browning and Travagli, 2010). Neurons of the NTS 
project to the hypothalamus and pre-sympathetic areas of the ventral brainstem as 
well; therefore the nucleus is well-situated to regulate premotor sympathetic and 
parasympathetic output (Takenaka et al., 1995; Fontes et al., 2001; Irnaten et al., 
2001; Affleck et al., 2012; Zoccal et al., 2014). NTS neurons have been shown to 
alter their function in response to many disease states, including hypertension, 
hypoxia, and diabetes, and a reduction in voltage-gated K+ current as been shown 
to be associated with these pathologies (Mei et al., 2003; Kline et al., 2005; Bach 
et al., 2015; Boychuk et al., 2015a). While voltage-gated K+ currents have been 
investigated in hypertension and hypoxia (Belugin and Mifflin, 2005; Accorsi-
Mendonca et al., 2015), epilepsy-related changes in voltage-gated K+ currents of 
NTS neurons have not been examined in a mouse model of acquired TLE. We 
postulate that a portion of the hyperexcitability previously seen in GABAergeric 
NTS neurons in TLE may be due to a similar reduction in voltage-gated K+ current.  
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Several voltage-gated K+ channels are known to be associated with 
epilepsy and are expressed in NTS neurons (Moak and Kunze, 1993; Kline et al., 
2005; Ramirez-Navarro et al., 2011; Villa and Combi, 2016). Of particular interest 
is the Kv4 family of voltage-gated K+ channels, which underlie the A-type K+ current 
in NTS neurons (Belugin and Mifflin, 2005; Bailey et al., 2007; Strube et al., 2015). 
Voltage-gated K+ channels play a major role in neuronal excitability and K+ 
channelopathies can contribute to seizures (Brenner and Wilcox, 2012; D'Adamo 
et al., 2013; Villa and Combi, 2016). The Kv4 family of voltage-gated K+ channels 
prevent action potential back-propagation and regulate neuronal excitability 
(Birnbaum et al., 2004). There are three subunits that comprise the Kv4 subfamily: 
Kv4.1, Kv4.2, and Kv4.3. There are also four K+ channel interacting proteins 
(KChIPs) that can modulate Kv4 activity and surface expression (Birnbaum et al., 
2004; Covarrubias et al., 2008). The Kv4.2 subunit has specifically been 
associated with TLE and mutations in KCND2, which encodes for the Kv4.2 
subunit, have been shown to occur in individuals diagnosed with TLE (Singh et al., 
2006; Lee et al., 2014). Additionally, when Kv4.2 is deleted in mice, susceptibility 
to kainite-induced seizures is increased (Barnwell et al., 2009). Several studies 
have shown a downregulation in Kv4.2, KChIPs, and A-type K+ currents following 
pilocarpine-induced status epilepticus (SE). Importantly, these changes occurred 
not only in the days following SE, but in the chronic seizure phase, months post-
SE (Lugo et al., 2008; Monaghan et al., 2008; Su et al., 2008). However, A-type 
K+ current has not been examined in NTS neurons in a mouse model of TLE. 
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We hypothesize that there is an alteration in A-type K+ current and Kv4 
expression is associated with increased excitability of GABAergic NTS neurons 
that develops during temporal lobe epileptogenesis. Increased excitability in this 
neuronal subtype may decrease the threshold for spreading depolarization, 
leading to an increased risk for cardiorespiratory collapse and SUDEP. We used 
the pilocarpine-induced SE model of TLE to test this hypothesis (Shibley and 
Smith, 2002; Winokur et al., 2004; Derera et al., 2017).  
4.2 Methods 
4.2.1  A-Type Potassium Current Recordings 
A-type K+ current (IA) activation and inactivation were measured in 
GABAergic NTS neurons using a series of voltage-step protocols. Total K+ currents 
(IK) were determined using the following protocol: from holding potential (-70 mV), 
a 500 ms hyperpolarizing pre-pulse (-110 mV) was delivered followed by a series 
of depolarizing voltage steps (-60 mV to +30 mV; 500 ms; 10 mV increments), 
evoking transient and sustained outward currents. The delayed rectifier K+ current 
(IKDR) was determined by delivering a 500 ms depolarizing pre-pulse at -30 mV 
from holding potential (-70 mV) followed by 500 ms depolarizing voltage steps from 
-60 mV to +30 mV in 10 mV increments. IA was calculated by offline subtraction of 
IKDR from IK in Clampfit 10.3 (Molecular Devices). IA inactivation was revealed with 
the following protocol: from holding potential (-70 mV), conditioning steps from         
-120 mV to +60 mV (10 mV increments, 500 ms duration), were followed by a test 
pulse at -30 mV (500 ms duration). The ACSF for all IA recordings contained 
tetrodotoxin (TTX, 1 µM), bicuculline (BIC, 30 µM), kynurenic acid (KYN, 1mM), 
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and tetraethylammonium chloride (TEA-Cl, 10 mM). In order to confirm the 
presence of IA, 4-AP (5mM) was added to the ACSF, and the activation and 
inactivation protocols were repeated. Current is presented as pA/pF in order to 
adjust for differences in cell size. Series resistance was less than 15 MΩ and 
compensated between 30% and 70% for all recordings. Series resistance was 
evaluated between each voltage-step protocol to ensure cell health. 
4.2.2 qRT-PCR 
Three to four brainstem slices per animal that contained the vagal complex 
(300 µM) were isolated as previously described for electrophysiological recordings. 
The vagal complex, including the NTS, was visualized under a dissecting 
microscope and excised from the rest of the brainstem using a 1 mm diameter 
punch (Miltex Inc., York, PA). This approach allowed for a more homogenous 
tissue sample with minimal sampling from other brainstem areas (Boychuk et al., 
2015a; Halmos et al., 2015; Boychuk et al., 2017). Tissue samples from one animal 
were pooled into one sample. RNA was isolated using the RNeasy miniPrep kit 
(Qiagen, Hilden Germany). Spectrophotometry (ThermoScientific, NanoDrop 2000 
Spectrophotometer) was used to determine cDNA quality and quantity. All qRT-
PCR reactions were run in triplicate in 96-well optical grade plates using a 7500 
Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). Total volume 
for each run was 20 µL containing 50-100 ng of cDNA. The reaction times and 
temperatures were 50˚C for 2 minutes, 95 ̊ C for 10 minutes, followed by 50 cycles 
of 95 ˚C for 15s, and 60 ˚C for 1 minute. Primers and probe sets for -actin 
(Mm.PT.39a.22214843), Kv4.1(mostly microglia; Mm.PT.58.1430675), Kv4.2 
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(oligodendrocytes and neurons; Mm.PT.58.29624161), Kv4.3 (neurons); 
Mm.PT.58.7819122, KChIP1 (neurons; Mm.PT.58.41994313), KChIP3 
(astrocytes; Mm.PT.58.43828062) and KChIP4 (neurons; Mm.PT.58.9880505) 
were purchased from Integrated DNA Technologies (IDT, Skokie, IL). Fold change 
in each gene of interest was calculated using the formula 2-CT; -actin was used 
as a reference gene. Water-only (i.e. no primer/probe) and no-RT controls were 
also run in each reaction. The positive control contained the whole brainstem 
instead of the vagal complex tissue sample (Livak and Schmittgen, 2001). The 
CT was used to determine statistical significance using an unpaired t-test (Wood 
and Giroux, 2003). 
Methods for Chapter 4 also included: methylscopolamine and pilocarpine 
injections, brainstem slice preparation, and whole-cell patch-clamp 
electrophysiology as described in Chapter 2 of this dissertation. 
4.3 Results 
4.3.1 Action potential frequency and half-width are altered in GABAergic 
NTS neurons from Pilo-SE mice 
In order to investigate the hyperexcitability seen in GABAergic NTS neurons 
during epileptogenesis, we assessed action potential firing frequency and half-
width in control and pilo-SE mice 9-12 weeks post-treatment. Action potential 
frequency was significantly greater in GABAergic NTS neurons from pilo-SE mice 
(2.54  0.37 Hz, n = 10 cells) compared to control mice (1.46  0.24 Hz, n = 11 
cells, p = 0.03, Fig. 4.1A,C). When measured at a membrane potential of -70 mV, 
action potential half-width was significantly greater in GABAergic NTS neurons 
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from pilo-SE mice (2.14  0.16 ms, n = 10 cells) compared to control mice (1.69  
0.13 ms, n = 11 cells, p = 0.04, Fig. 4.1B,D). The increase in action potential half-
width in neurons from pilo-SE mice is suggestive of a lengthening in the 
repolarization phase of the action potential. 
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Figure 4.1 GABA NTS neurons from pilo-SE mice have increased action potential 
firing frequency and half-width.  
(A) Representative traces showing action potential firing in GABAergic NTS 
neurons from a control and pilo-SE animal. (B) Representative traces showing 
action potential half-width in GABAergic NTS neurons from a control and pilo-SE 
animal. (C) Action potential frequency is significantly increased in GABAergic NTS 
neurons from pilo-SE mice (unpaired t-test; *p < 0.05). (D) Action potential half-
width is significantly increased in GABAergic NTS neurons from pilo-SE mice 
(unpaired t-test; *p < 0.05). 
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Various families of voltage-gated K+ channels modulate the repolarization 
phase of the action potential. We hypothesized that in pilo-SE mice there may be 
a decrease in voltage-gated K+ channel function that contributes to both the 
increase in the action potential half-width and the hyperexcitability seen in 
GABAergic NTS neurons. In order to test this hypothesis, we measured action 
potential frequency and half-width before and after bath application of 4-AP (5 
mM), a voltage-gated K+ channel blocker, in GABAergic NTS neurons from control 
and pilo-SE mice 9-12 weeks post-treatment. Action potential frequency was 
significantly greater after application of 4-AP in GABAergic NTS neurons from 
control mice (no 4-AP: 1.56  0.31 Hz, n=13 cells; after 4-AP: 3.1  0.65 Hz, n= 6 
cells, p = 0.02). However, there was no significant difference in action potential 
frequency in GABAergic NTS neurons in normal ACSF (3.20  0.32, n = 13 cells) 
and after application of 4-AP (4.39  0.82, n= 8 cells, p = 0.13 Fig. 4.2). When 
examining action potential half-width, we found that it was significantly longer after 
application of 4-AP in GABAergic NTS neurons control mice (before 4-AP: 1.63  
0.15 ms, n=8 cells; after 4-AP: 3.52  0.42ms, n= 5 cells, p = 0.0005). We did not 
detect a significant difference in action potential half-width in GABAergic NTS 
neurons from pilo-SE mice in the absence (2.63  0.44 ms, n= 10 cells) or presence 
(2.90  0.22 ms, n= 6 cells, p = 0.66, Fig. 4.3) of 4-AP. The decrease in sensitivity 
to 4-AP seen in GABAergic NTS neurons from pilo-SE mice suggests that there 
may be a decrease in the function of voltage-gated K+ channels, potentially those 
contributing to the A-type current.  
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Figure 4.2 The effect of 4-AP on action potential firing frequency in GABA NTS 
neurons.  
(A) Representative trace showing action potential firing in a GABA NTS neuron 
from a control animal in normal ACSF (nACSF). (B) Action potential firing in the 
same GABA NTS neuron in the presence of 4-AP (5mM). (C) Representative trace 
showing action potential firing in a GABA NTS neuron from a pilo-SE mouse in 
nACSF. (D) Representative trace showing action potential firing in the same GABA 
NTS neuron in the presence of 4-AP. (E) Action potential frequency is significantly 
higher after application of 4-AP in GABA NTS neurons form control mice. There is 
no significant difference in action potential frequency before and after 4-AP 
application in GABA NTS neurons from pilo-SE mice (unpaired t-test; *p < 0.05).  
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Figure 4.3 GABA NTS neurons from pilo-SE mice are less sensitive to 4-AP.  
(A) Representative traces showing action potential half-width in a GABAergic NTS 
neuron from a control animal in normal ACSF (nACSF) and in the presence of 4-
AP (5mM). (B) Representative traces showing action potential half-width in a 
GABAergic NTS neuron from a pilo-SE mouse in nACSF and in the presence of 4-
AP. (C) Action potential half-width is significantly increased in GABAergic NTS 
neurons from control mice after 4-AP application. There is no significant difference 
in action potential half-width before and after 4-AP application in GABA NTS 
neurons from pilo-SE mice (unpaired t-test; *p < 0.05).  
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4.3.2 The effect of 4-AP on sEPSC frequency and amplitude in 
GABAergic NTS neurons 
 We also assessed the effect of 4-AP on frequency and amplitude of 
sEPSCs in GABAergic NTS neurons from control and pilo-SE mice 9-12 weeks 
post-treatment. There was a significant increase in sEPSC frequency in 
GABAergic NTs neurons after application of 4-AP (before 4-AP: 1.17  0.23 Hz, 
n= 7 cells; after 4-AP: 5.34  0.78 Hz, n= 7, p = 0.003). sEPSC frequency was not 
significantly different following 4-AP application (before 4-AP: 3.77  0.87 Hz, n= 
6 cells; after 4-AP: 4.54  0.74 Hz, n= 14 cells, p = 0.55). Application of 4-AP had 
no significant effect on sEPSC amplitude in either control or pilo-SE mice (control: 
p = 0.59; pilo-SE: p = 0.67; Fig. 4.4). Changes in synaptic frequency with addition 
of 4-AP are consistent with previous studies in both the hippocampus (Buckle and 
Haas, 1982) and NTS (Haji and Ohi, 2010), and the absence of detectable change 
in pilo-SE mice suggests a functional reduction in 4-AP sensitive channels in 
GABA NTS neurons. 
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Figure 4.4 The effect of 4-AP on sEPSC frequency and amplitude in GABA NTS 
neurons.  
(A, B) Representative traces showing sEPSCs in a GABA NTS neuron from a 
control animal in normal ACSF (nACSF) and in the presence of 4-AP (5mM). (C,D) 
Representative traces showing sEPSCs in a GABA NTS neuron from a pilo-SE 
animal in nACSF and in the presence of 4-AP. (E) There is significantly higher 
sEPSC frequency in GABA NTS neurons from control mice after 4-AP and no 
significant difference in pilo-SE mice after 4-AP application (unpaired t-test; *p < 
0.05). (F) There is no significant difference in sEPSC amplitude before and after 
4-AP application in GABA NTS neurons from control or pilo-SE mice (unpaired t-
test; p > 0.05).  
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4.3.3 A-type potassium current is reduced in GABA NTS neurons from 
pilo-SE mice 
Since 4-AP is a specific blocker of A-type K+ currents, we hypothesized that 
the decrease in sensitivity to 4-AP in pilo-SE mice may be due a decrease in A-
type K+ current. First, we assessed the amplitude of the transient outward currents 
(TOCs) in GABAergic NTS neurons from control and pilo-SE mice. The membrane 
capacitance was not different between GABAergic NTS neurons from control and 
pilo SE mice (control: 6.57  0.20 pF; pilo-SE: 7.39  0.79 pF; p = 0.14). The series 
resistance also did not differ between groups (control: 8.69  0.76 MΩ; pilo-SE: 
7.86  1.29 MΩ; p = 0.59). The amplitude of the TOCs (measured 20-30 ms after 
the voltage step onset) were significantly different between GABAergic NTS 
neurons from control and pilo-SE mice (F (9,160) = 1.96, P = 0.04, control n= 10 
cells, pilo-SE n=8 cells, Fig 4.5C). At activation voltages from +10 to +30 mV, the 
TOCs were significantly reduced in GABAergic NTS neurons from pilo-SE mice 
compared to control mice (+10 mV: p = 0.04; +20 mV: p = 0.01; +30 mV: p = 0.003). 
We did not see any significant differences in longer-lasting steady state amplitude 
in GABAergic NTS neurons between control and pilo-SE mice (F 9,160) = 0.18, P 
= 0.99, Fig 4.5D), measured in the last 50 ms of the voltage step. In a separate 
cohort of GABAergic NTS neurons, 4-AP was added to the bath solution in order 
to validate that the A-type voltage-gated K+ current was being measured (Fig 4.6). 
We also examined the voltage dependence of activation and inactivation in 
GABAergic NTS neurons from control and pilo-SE mice. There was no significant 
difference in the voltage dependence of activation (2-way ANOVA, F (9,330) = 
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0.21, p = 0.99, Fig 4.7A) or inactivation (2-way ANOVA, F (18, 475) = 0.18, p = 
0.99, Fig 4.7B) in GABAergic NTS neurons from control mice and pilo-SE mice. 
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Figure 4.5 Transient outward current amplitude is reduced in pilo-SE mice.  
(A) Representative trace of IA activation in a GABAergic NTS neuron from a control 
animal. (B) Representative trace of IA activation in a GABAergic NTS neuron from 
a pilo-SE animal. (C) Mean amplitude of TOCs (measured as peak-steady state 
values). GABA NTS neurons from pilo-SE mice had significantly lower TOCs 
compared to those from control mice (2-way ANOVA, *P < 0.05). (D) There was 
no significant difference in steady-state outward currents in GABA NTS neurons 
from control and pilo-SE mice (2-way ANOVA, p > 0.05). 
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Figure 4.6 The effect of 4-AP on transient outward current amplitudes in 
GABAergic NTS neurons.  
(A) Representative trace of IA activation in a GABAergic NTS neuron from a 
control animal in normal ACSF (nACSF) and in the presence of 4-AP (5 mM). (B) 
Representative trace of IA activation in a GABAergic NTS neuron from a pilo-SE 
animal in nACSF and in the presence of 4-AP. (C) 4-AP significantly reduced 
TOCs in GABAergic NTS neurons from both control and pilo-SE mice (2-way 
ANOVA, *p < 0.05).  
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Figure 4.7 Activation and Inactivation of TOCs in GABAergic NTS neurons from 
control and pilo-SE mice.   
(A) Voltage dependence activation of TOCs in GABAergic NTS neurons from 
control and pilo-SE mice. (B) Voltage dependence inactivation of TOCs in 
GABAergic NTS neurons from control and pilo-SE mice.  (2-way ANOVA, p > 
0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 91 
4.3.4 Quantitative reverse transcriptase PCR 
 Quantitative RT-PCR was utilized to determine if the reduction in IA is due 
to a down regulation in the expression of the genes that encode the Kv4 subfamily 
of voltage-gated K+ channels and their associated accessory subunits, KChIP1, 
KChIP3, and KChIP4. There were no significant differences in the expression of 
any Kv4 genes or their associated accessory subunits in pilo-SE mice relative to 
control mice (Kv4.1: p = 0.81; Kv4.2: p = 0.83; Kv4.3: p = 0.81; KChIP1: p = 0.61; 
KChIP3: p = 0.40; KChIP4: p = 0.47; Fig. 4.8).  
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Figure 4.8 Kv4 and KChIP expression levels in the vagal complex from control 
and pilo-SE mice.  
There was no significant difference in expression of Kv4.1, Kv4.2, Kv4.3, KChIP1, 
KChIP2, KChIP3, or KChIP4 (Unpaired t-test, p > 0.05).  These analyses were 
performed by Dr. Katalin Smith. 
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4.4 Discussion 
The present study investigated the 4-AP sensitive A-type voltage-gated K+ 
current in a mouse model of pilocarpine-induced TLE. Previous studies have 
shown that there is a downregulation in the A-type current as well as voltage-gated 
K+ channel protein in the hippocampus of pilocarpine-treated mice. This change 
was seen both in the hours and months following SE induction (Lugo et al., 2008; 
Monaghan et al., 2008; Su et al., 2008). SUDEP in genetic epilepsy models 
established by Kv1.1 channelopathy have been described in the NTS (Glasscock 
et al., 2010; Vanhoof-Villalba et al., 2018). Since the channelopathies induced the 
epilepsy phenotype, however, the relevance of the seizure disorder to autonomic 
dysfunction and SUDEP cannot be easily separated from the effect of the channel 
mutation itself in these models. Conversely, the functional modification of voltage-
gated channels described here develops concurrently with epileptogenesis, 
implying that epilepsy-related changes in channel function can contribute to central 
vagal dysfunction in acquired epilepsy.  
There have been several previous studies examining functional plasticity of 
NTS neurons in other disease states (Mei et al., 2003; Belugin and Mifflin, 2005; 
Kline et al., 2005; Dergacheva et al., 2013; Bach et al., 2015; Boychuk et al., 
2015a; Boychuk and Smith, 2016). We have also recently shown that in the 
pilocarpine-induced SE model of TLE, GABAergic NTS neurons display 
hyperexcitability 6 and 12 weeks post-SE (Derera et al., 2017). The A-type current 
has been described in NTS neurons (Moak and Kunze, 1993; Bailey et al., 2002; 
Bailey et al., 2007) and prominently regulates neuronal excitability and action 
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potential morphology and repolarization. We first examined action potential 
frequency and half-width and found that they were significantly increased in 
GABAergic NTS neurons from pilo-SE mice compared to control mice suggesting 
a decrease in the function of the voltage-gated K+ currents that underlie action 
potential repolarization develops during epileptogenesis. More specifically, the 
decrease in sensitivity of GABAergic NTS neurons from pilo-SE mice to 4-AP 
suggests a reduction in A-type voltage-gated K+ current and Kv4 channel function.  
The effect of 4-AP on synaptic activity in GABAergic NTS neurons between 
control and pilo-SE mice was also assessed. We found that 4-AP elicited a 
significant increase in sEPSC frequency, consistent with an increase in 
presynaptic excitatory neurotransmission. This effect of 4-AP has previously been 
shown in CA1 pyramidal neurons, as well as in NTS neurons involved in the cough 
reflex (Buckle and Haas, 1982; Gu et al., 2004; Haji and Ohi, 2010). Interestingly, 
we did not observe a similar increase in sEPSC frequency in GABAergic NTS 
neurons from pilo-SE mice. These neurons already receive an increase in 
excitatory neurotransmission (Derera et al., 2017), and combined with the 
alterations in voltage-gated K+ current, may contribute to the lack of effect of 4-AP 
in neurons from pilo-SE mice. Similar to what was reported by others (Haji and 
Ohi, 2010), there was no significant effect of 4-AP on sEPSC amplitude in either 
group. Overall, the exact mechanism as to why there is not a significant increase 
in sEPSC frequency with 4-AP in pilo-SE mice, needs to be fully elucidated and 
the increase in excitatory neurotransmission may be one factor of many that is 
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contributing to the hyperexcitability of GABAergic NTS neurons in this model of 
TLE.  
The Kv4 subfamily of voltage-gated K+ channels is the primary regulator of 
the A-type current and includes the Kv4.1, Kv4.2, and Kv4.3 subunits, which are 
widely expressed in brain tissue (Rudy, 1988; Salkoff et al., 1992; Birnbaum et al., 
2004; Covarrubias et al., 2008). More specifically, immunolabelling has revealed 
the presence of Kv4.2 and Kv4.3 subunits in neurons of the NTS (Strube et al., 
2015). Our data on average TOC amplitude and voltage dependence of activation 
and inactivation in control animals are consistent with results from previous studies 
in NTS neurons (Moak and Kunze, 1993; Bailey et al., 2002). Interestingly, we 
found a reduction in average TOC amplitude in GABAergic NTS neurons from pilo-
SE mice, but no changes in voltage-dependent activation or inactivation were 
observed. This suggests that there may be a decrease in the number of voltage-
gated K+ channels at the membrane, rather than an alteration in the channel or 
voltage-sensing pore contributing to a reduction in the A-type current amplitude.  
The cellular mechanisms involved in Kv4 membrane expression and 
function in TLE in the NTS remains to be elucidated. We did not detect a significant 
decrease in the molecular expression of Kv4.1, Kv4.2, or Kv4.3 in pilocarpine-
treated mice relative to control mice. IA can also be modulated via KChIPs, which 
associate with Kv4 subunits and increase their surface expression and 
conductance (Hoffman et al., 1997; Beck et al., 2002; Lien et al., 2002; Birnbaum 
et al., 2004; Covarrubias et al., 2008). Previous studies suggest that expression of 
these accessory subunits is reduced in pilocarpine-treated mice (Monaghan et al., 
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2008; Su et al., 2008). Upon measuring mRNA levels of KChIP1, KChIP3, and 
KChIP4 there was no significant difference in expression in pilocarpine-treated 
mice relative to controls. Kv4 function and expression can be altered in several 
different ways other than through accessory subunit modulation. A decrease in the 
export of Kv4 subunits from the endoplasmic reticulum, potentially via 
phosphorylation of the PDZ domain of the channel can also decrease surface 
expression of the channel (Birnbaum et al., 2004). Once the Kv4 channel is 
shuttled from the endoplasmic reticulum to the membrane, surface expression and 
channel opening can also be modified through phosphorylation by several kinases, 
including protein kinase C (PKC), protein kinase A (PKA), calmodulin-dependent 
protein kinase II (CAMKII), extracellular signal-related kinases/mitogen-activated 
protein kinases (ERK/MAPK), and protein tyrosine kinase (PTK) (Birnbaum et al., 
2004). It has been shown in kainate-induced SE, that a decrease in the surface 
expression Kv4.2 correlates with ERK phosphorylation of the channel suggesting 
additional mechanisms for a decrease in the A-type current associated with 
epilepsy (Lugo et al., 2008). An increase in PKC-mediated phosphorylation in 
concert with a decrease in channel expression has been shown to be associated 
with a reduction of IA in a rat model of TLE (Bernard et al., 2004). Other post-
translational modifications, such as glycosylation and palmitoylation are known to 
increase channel stability and enhance surface localization of the channel 
(Birnbaum et al., 2004), but if and how this may occur during epileptogenesis is 
unclear.  
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This region of the brain has played a significant role in the research for 
potential SUDEP mechanisms. A previous study using genetic epilepsy models 
has showed that after a chemically-induced cortical seizure spreads to the 
brainstem, NTS neurons undergo spreading depolarization and the animal suffers 
from cardiorespiratory collapse and death (Aiba and Noebels, 2015). In other brain 
regions, increases in neuronal excitability have been associated with a decreased 
threshold for spreading depression (Somjen, 2001; Dreier and Reiffurth, 2015). 
Additionally, previous studies in individuals with TLE have shown evidence of Kv4 
modification (Villa and Combi, 2016). We propose that reduced A-type current 
contributes to the increase in GABA NTS neuron hyperexcitability seen during TLE 
and that this may increase the risk for cardiorespiratory collapse. Understanding 
both the cellular mechanisms and functional consequences of alterations in the A-
type current in the context of TLE and SUDEP may allow for the development of 
novel biomarkers and/or treatment options for individuals at risk of sudden death. 
 
 
 
 
 
 
 
 
 98 
Chapter 5 Chemogenetic manipulation of GABA NTS neurons in TLE 
5.1 Introduction 
 Sudden unexpected death in epilepsy (SUDEP) is one of the leading causes 
of death in individuals with temporal lobe epilepsy (TLE), which comprises 60% of 
the total epilepsy population (Nashef, 1997; Tolstykh and Cavazos, 2013). Patients 
with TLE display autonomic dysfunction such has depressed heart rate variability 
and abnormal cardiac rhythms (Tomson et al., 1998; Mayer et al., 2004; Ronkainen 
et al., 2005; Suorsa et al., 2011; Romigi et al., 2016). Additionally, studies utilizing 
genetic epilepsy models have suggested that dysfunction in central autonomic 
control centers in the caudal brainstem are involved in SUDEP (Glasscock et al., 
2010; Aiba and Noebels, 2015).  
 The autonomic nuclei that receive information regarding cardiorespiratory 
function and subsequently modulate output to the periphery are located in the 
dorsal vagal complex (DVC) of the causal brainstem. The DVC receives 
viscerosensory information via the afferent fibers of the vagus nerve, which 
synapse onto neurons in the nucleus tractus solitarius (NTS). NTS neurons project 
to preganglionic motor neurons within the nucleus ambiguus and dorsal motor 
nucleus of the vagus (DMV) to regulate parasympathetic output (Andresen and 
Kunze, 1994; Doyle and Andresen, 2001; Wang et al., 2001b; Davis et al., 2004; 
Glatzer et al., 2007). We have recently shown that GABAergic neurons in the NTS 
are hyperexcitable in a mouse model of TLE (Derera et al., 2017). However, it is 
still unknown if direct GABAergic NTS neuron activation is involved in seizures or 
SUDEP.  
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 The aim of this study is to determine if selective activation of GABAergic 
NTS neurons can modulate in vivo seizure threshold and in vitro 
electrophysiological properties of neurons within the DVC.  An excitatory designer 
receptor exclusively activated by designer drugs (DREADDs) was used to 
selectively modulate GABAergic NTS neuron function in a mouse model of 
pilocarpine-induced TLE. Excitatory DREADDS have been used to modulate 
animal behavior in other brain regions and pathologies but have yet to been utilized 
in a mouse model of TLE and SUDEP (Armbruster et al., 2007; Urban and Roth, 
2015; Roman et al., 2017). We hypothesized that if GABAergic NTS neurons are 
directly involved in TLE, activation of these neurons via an excitatory DREADD 
may either induce a seizure or decrease seizure threshold in TLE mice.  
5.2 Methods 
5.2.1 Stereotaxic Injection of DREADD Virus 
 Four weeks after pilocarpine or vehicle treatment, age-matched Vgat-ires-
Cre mice were injected with the excitatory DREAAD, pAAV8-hSyn-DIO-
hM3D(Gq)-mCherry into the NTS (pAAV8-hSyn-DIO-hM3D(Gq)-mCherry was a 
gift from Bryan Roth, Addgene, Cambridge, MA; plasmid #44361) (Krashes et al., 
2011). Mice were weighed and placed under 5% isofluorane and 1.5% 100% O2 
for initial anesthesia. Once the animal was fully anesthetized, isofluorane was 
reduced to 2.5 % with 1.5% 100% O2 and the animals head was shaved. Animals 
were then placed in a stereotaxic device and given a subcutaneous injection of the 
analgesic buprenorphine (0.1 mg/kg in 0.9% saline) to mitigate post-operative 
pain. A midline incision was made across the scalp and bregma, lambda, and the 
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occipital bone were exposed. Stereotaxic coordinates were measured from 
bregma: AP: 7.0, ML: 0.1, DV: 0.36. A drill was used to make small hole (<1 mm 
in diameter) at the injection site and 250-500 nL of pAAV8-hSyn-DIO-hM3D(Gq)-
mCherry was slowly injected into the NTS. Mice were given 1 mg/kg carprofen 
post-operatively. After 10-14 days sutures were removed. Mice were used for in 
vivo and in vitro studies 3-4 weeks after the injection of the DREADD.  
5.2.2 Flurothyl-Induced Seizures 
 Flurothyl (Bis(2,2,2-trifluroethyl)ether (10% flurothyl in 95% ethanol; Sigma) 
was used to induced a single acute seizure in Vgat-ires-Cre control and pilo-SE 
mice 3 weeks after intracranial injection of pAAV8-hSyn-DIO-hM3D(Gq)-mCherry. 
All experiments using flurothyl were performed within a certified fume hood. Mice 
were given an i.p. injection of either saline mixed with DMSO or CNO (1mg/kg) 15-
20 minutes prior to being exposed to flurothyl. Each animal received the opposite 
treatment 3-4 days later to have a counter-balanced design. The 10% flurothyl was 
dripped at a rate of 6 mL/hour with a syringe pump (KD Scientific, Holliston, MA) 
onto a gauze pad within the plexiglass container. One animal at a time was placed 
in the container for each trial. Once the animal developed a seizure (i.e. loss of 
posture), the flurothyl was stopped and the animal was exposed to open air, after 
which the seizure ended (Kadiyala et al., 2016; Ferland, 2017; Kadiyala and 
Ferland, 2017).  Once the animal resumed normal behaviors (i.e. after five to 10 
minutes), it was returned to its home cage and the latency to seize was recorded.  
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5.2.3 Electrophysiological Recordings 
 Brainstem slices were transferred to a chamber mounted on a fixed stage 
under an upright microscope (BX51WI; Olympus) where they were superfused with 
continuously warmed (30-32C) oxygenated ACSF. VGAT-containing neurons in 
the NTS that were transfected with pAAV8-hSyn-DIO-hM3D(Gq)-mCherry, were 
mCherry-expressing and were targeted under epifluorescence (Krashes et al., 
2011). DMV neurons were targeted based on their morphological characteristics 
(Bach and Smith, 2012; Bach et al., 2015). Patch pipettes for recordings were 
pulled from borosilicate glass (open tip resistance 3-5 M; King Precision Glass 
Co, Claremont, CA). The pipette solution contained (in mM): 130 K+ gluconate, 1 
NaCl, 5EGTA, 10 HEPES, 1 MgCl2, 1 CaCl2, 3 KOH, 2 ATP. Recordings were 
obtained using an Axon 700B amplifier (Molecular Devices; San Jose, CA), low 
pass filtered at 2-3 kHz, digitized at 20 kHz, and recorded onto a computer 
(Digidata 1440A, Molecular Devices).  
 Prior to recording, cells were allowed to equilibrate with the pipette 
recording solution for approximately five minutes. Whole-cell patch clamp 
recordings of spontaneous action potentials in NTS neurons were recorded in 
current-clamp at resting membrane potential. Resting membrane potential was 
recorded in I=0 in NTS neurons. Spontaneous inhibitory postsynaptic currents 
(sIPSCs) were recorded in voltage-clamp in DMV neurons. DMV neurons were 
clamped at a holding potential of 0 mV to isolate inhibitory currents. The effect of 
clozapine-N-oxide (CNO, 30 M) was assessed on resting membrane potential 
and action potential frequency in NTS neurons and on sIPSC frequency and 
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amplitude in DMV neurons from control and pilo-SE mice. Series resistance was 
less than 25 M and monitored periodically throughout the recordings. If the series 
resistance changed by more than 20% over the course of a recording, it was 
discarded.  
5.2.4 Statistical Analyses 
 A repeated measures two-way ANOVA (Tukey’s post hoc) was used to 
determine the effect of CNO treatment on flurothyl induced seizure latency 
between control and pilo-SE mice (GraphPad Prism; La Jolla, CA). Action potential 
frequency (2-minute recording segment) and resting membrane potential were 
analyzed using Clampfit 10.2 (Molecular Devices). Two-minute segments of 
continuous recordings of sIPSCs from DMV neurons was assessed with 
MiniAnalysis (Synaptosoft, Decatur, GA). For electrophysiology data, a paired t-
test was used to determine the effect of CNO on NTS and DMV neurons from 
control and pilo-SE mice. Statistical significance for all measurements was set at 
p < 0.05.  
Methods for Chapter 5 also included: mice used, methylscopolamine and 
pilocarpine injections, and brainstem slice preparation as described in Chapter 2 
of this dissertation. 
5.3 Results 
5.3.1 Spontaneous Seizures 
It has been previously established in various mouse strains that pilocarpine-
induced SE leads to the development of chronic spontaneous seizures four to six 
weeks after treatment (Shibley and Smith, 2002; Groticke et al., 2007). However, 
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spontaneous seizure development has not yet been established in the Vgat-ires-
Cre mouse strain. Mice were passively monitored for seizures as described in 
Chapter 2 beginning at four weeks post-pilocarpine treatment. None of the mice 
that received vehicle treatment or did not have SE developed spontaneous 
seizures, whereas 100% of mice that survived pilocarpine-induced SE developed 
spontaneous seizures (Table 5.1). 
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Table 5.1 Development of spontaneous seizures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Spontaneous Seizures 
 
Occurrence in 
SE survivors 
Days after SE to 1st 
Spontaneous Seizure 
Seizure Rate 
(seizures/h) 
Control (n=4)  -    -   0 
Mice that survived SE (> 
3 S3 seizures; n=3) 100% 
48.67 ± 16.44 (range: 30-
61) 0.13 ± .04 
Mice that died during SE 
(n=8)  -    -    -   
Non-SE mice (n=3) 0%  -   0 
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5.3.2 Effect of GABAergic NTS neuron activation on Flurothyl-Induced 
Seizure Latency  
 Control and pilo-SE mice were randomly administered either CNO or saline 
and the latency to seize upon flurothyl exposure was measured. Three to four days 
later, animals that were previously given saline, received CNO treatment, and vice-
versa. A repeated measures two-way ANOVA showed a significant interaction 
effect between saline and CNO administration in control and pilo-SE mice 
(F(1,13)=5.71; p = 0.03). Pilo-SE mice had a significantly shorter seizure latency 
(462  37 sec; n=7 mice) compared to control mice (609  38 sec; n=8 mice; p = 
0.03) when administered saline. While CNO did not significantly alter seizure 
latency in pilo-SE mice (saline: 462  37 sec; CNO: 482  37 sec; n=7 mice; p = 
0.99), it did significantly shorten the seizure latency in control mice (saline: 609  
38 sec; CNO: 458  22 sec; p = 0.02, Fig.5.1).  
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Figure 5.1 Chemogenetic modulation of seizure latency in control and pilo-SE 
mice.  
There was a significantly shorter latency to seize in pilo-SE mice (n=7) compared 
to control mice (n=8) when treated with saline. CNO alone reduced seizure latency 
in control mice, but this did not further shortern the latency in pilo-SE mice. (p > 
0.05). Two-way repeated measures ANOVA: F (1,13) = 5.71; p = 0.03. *p < 0.05.  
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5.3.3 GABAergic NTS neuron activation in control and pilo-SE mice 
 The effect of GABAergic NTS neuron activation on action potential 
frequency and resting membrane potential was assessed in control and pilo-SE 
mice. The resting membrane potential was significantly more depolarized after 
CNO application in control mice (ACSF: -46.06 ± 1.48 mV; CNO: -42.57 ± 0.76 
mV; p = 0.02, n= 10 cells, Fig. 5.2D). Activation of GABAergic NTS neurons from 
pilo-SE mice also had a significantly depolarized resting membrane potential 
(ACSF: -45.83 ± 0.82 mV; CNO: -41.21 ± 1.06 mV; p = 0.001; n=10 cells Fig. 5.2D). 
In the same cells, the CNO-induced activation of GABAergic NTS neurons was 
concomitant with an increase in action potential frequency in both control (ACSF: 
1.72 ± 0.39 Hz; CNO: 2.36 ± 0.38 Hz; p = 0.03; n=10 cells) and pilo-SE mice 
(ACSF: 2.49 ± 0.47 Hz; CNO: 3.90 ± 0.80 Hz; p = 0.03; n=10 cells; Fig. 5.2C). 
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Figure 5.2 Chemogenetic modulation of GABAergic NTS neurons from control 
and pilo-SE mice.  
(A) Illustration of pipette location in the NTS. (B) Representative image of 
mCherry expression in the NTS four weeks after DREADD injection. (C) 
Representative traces showing the effect of clozapine-N-oxide (CNO, 30 µM) on 
action potential firing in a GABAergic NTS neuron from a control animal. (D) 
Representative traces showing the effect of CNO on action potential firing in 
GABAergic NTS neuron from a pilo-SE animal. (E) CNO significantly increases 
the action potential frequency in control mice and pilo-SE mice. (F) CNO 
significantly depolarizes membrane potential in GABAergic NTS neurons from 
control and pilo-SE mice. Sample Sizes: control: n=8 mice; pilo-SE: n=8 mice. *p 
< 0.05.  
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5.3.4 Inhibition of Vagal Motor Neurons via GABAergic NTS Neuron 
Activation 
 GABAergic NTS neurons project to preganglionic parasympathetic motor 
neurons in the DMV (Travagli et al., 1991; Davis et al., 2004; Babic et al., 2011). 
We tested the hypothesis that activation of mCherry-expressing NTS neurons 
would increase inhibition of DMV neurons, assessed via sIPSC frequency and 
amplitude. GABAergic NTS neuron activation in slices from control animals 
significantly increased sIPSC frequency (ACSF: 0.53 ± 0.1 Hz; CNO: 0.96 ± 0.21 
Hz; p = 0.02) but not amplitude (ACSF: 36.97 ± 4.45 pA; CNO: 30.73 ± 1.75 pA; p 
= 0.22; n=6 cells) of DMV neurons. There was a similar effect in DMV neurons 
from pilo-SE mice, where sIPSC frequency increased (ACSF: 0.98 ± 0.35 Hz; 
CNO: 1.72 ± 0.45 Hz; p = 0.001), but there was no significant change in amplitude 
(ACSF: 43.39 ± 9.20 pA; CNO: 53.58 ± 19.28 pA; p = 0.48; n=8 cells; Fig. 5.3). 
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Figure 5.3 Inhibition of preganglionic parasympathetic motor neurons in control 
and pilo-SE mice.  
(A) Representative traces showing the effects of CNO (30 µM) on sIPSCs in a 
DMV neuron from a control mouse. (B) Representative traces showing the effect 
of CNO on sIPSCs in a DMV neuron from a pilo-SE mouse. (C) Application of CNO 
significantly increases sIPSC frequency in DMV neurons from control and and pilo-
SE mice. (D) CNO does not significantly alter sIPSC amplitude in DMV neurons 
from control and pilo-SE mice. Sample sizes: control: n=4 mice; pilo-SE: n=5 mice. 
*p < 0.05.  
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5.4 Discussion 
Previous research has utilized DREADDs to excite or inhibit specific 
neuronal subtypes in order to modulate whole animal behavior and neuron function 
(Krashes et al., 2011; MacLaren et al., 2016; Roth, 2016; Whissell et al., 2016). 
Inhibitory DREADDs have been used to block seizure activity in organotypic slice 
cultures and kindling models (Avaliani et al., 2016; Wicker and Forcelli, 2016). 
While blocking seizure activity with inhibitory DREADDs in these studies has been 
successful, there have been no studies using excitatory DREADDs to induce 
seizure activity. This study tested the hypothesis that activation of GABAergic NTS 
neurons via the excitatory DREADD, pAAV8-hSyn-DIO-hM3D(Gq)-mCherry, can 
modulate whole animal seizure threshold and single vagal complex neuron activity.  
 We first investigated the effect of DREADD-mediated activation of 
GABAergic NTS neurons on animal behavior, namely on flurothyl-induced seizure 
latency. When pilo-SE mice received no treatment, their latency to seize was 
significantly shorter compared to control animals. While CNO did not appear to 
have a significant effect on seizure latency in pilo-SE mice, it did significantly 
reduce seizure latency in control mice.  This result was unexpected as I 
hypothesized that CNO would decrease seizure latency in pilo-SE mice when 
compared to control mice. Because GABAergic NTS neurons from pilo-SE mice 
have been shown to become hyperexcitable, it is possible that there is a ceiling 
effect, which could explain why CNO activation of mCherry-expressing NTS 
neurons does not further shorten seizure latency. Control animals did not exhibit 
any prior seizure activity and therefore may be more susceptible to a reduction in 
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seizure latency when mCherry-expressing neurons are activated via CNO 
administration. Aiba and Noebels have shown that when a seizure is chemically 
elicited in the cortex of an anesthetized mouse with Dravet’s Syndrome, it spreads 
to the brainstem initiating cardiorespiratory collapse and sudden death (Aiba and 
Noebels, 2015). Additionally, they have shown that chemically-induced 
depolarization of NTS neurons in Kv1.1 knockout mice results in seizure-like 
waveforms and brief EEG suppression in the cortex. This suggests that spreading 
depression in the brainstem effects cortical activity, supporting the hypothesis that 
seizures propagation can affect NTS function and vice-versa, potentially 
influencing SUDEP risk. Perhaps similar studies would be necessary for a seizure 
in pilo-SE mice administered CNO to occur.  
 There has also been concern that CNO may not be as specific as initially 
shown, as recent studies have suggested that CNO metabolizes into clozapine, 
which may produce off-target effects (Gomez et al., 2017; Manvich et al., 2018). 
While there is the possibility that this occurred in the whole animal studies, effects 
of CNO were seen in less than 5 minutes during in vitro slice electrophysiology. 
Electrophysiological results suggest that CNO increases excitation of GABAergic 
NTS neurons, subsequently leading to increased inhibition of downstream motor 
neurons that go on to regulate parasympathetic function. This would be expected 
to increase the inhibition of parasympathetic output to the periphery, thus leading 
to autonomic imbalance, similar to what is seen in patients with TLE (Ronkainen 
et al., 2005; Romigi et al., 2016). Additionally, GABAergic NTS neurons were 
slightly more sensitive to CNO-induced excitation (mV: control: 7.58%; pilo-SE: 
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10.08%). This small differential effect may partially be due to epileptogenesis this 
model.  
 These data show that pilo-SE mice have a reduced seizure latency and are 
more easily excited by CNO compared to control animals, leading to increased 
inhibition of preganglionic parasympathetic motor neurons. While CNO 
administration decreased seizure latency in control mice, the lack of effect in pilo-
mice suggests that increased excitability in GABAergic NTS neurons is not the sole 
factor responsible for influencing seizure threshold and contributing to SUDEP. 
Others have suggested that brainstem autonomic nuclei are the prime mediators 
of SUDEP in models of genetic epilepsy (Glasscock et al., 2010; Aiba and Noebels, 
2015), however, acquired epilepsies may be more complicated and SUDEP could 
be due to a multitude of factors including altered respiratory function (Ryvlin et al., 
2013; Sowers et al., 2013; Zhan et al., 2016). More work needs to be done 
examining the function of neurons in other brain regions that may contribute to 
SUDEP in concert with autonomic nuclei. This would provide greater insights to 
mechanisms of SUDEP and allow for the development of potential biomarkers or 
preventative treatment options.  
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Chapter 6 Discussion 
6.1 Summary of Findings 
 This dissertation focused on alterations in GABAergic NTS neuron function 
in a mouse model of pilocarpine-induced TLE and SUDEP. While several studies 
have used genetic epilepsy models to study SUDEP (Faingold et al., 2010; 
Glasscock et al., 2010; Cheah et al., 2012; Auerbach et al., 2013; Kalume et al., 
2013; Aiba and Noebels, 2015), this dissertation is the first to examine sudden 
death and NTS neuron function in a model of acquired TLE. The main findings of 
this dissertation are as follows: 1) the pilocarpine-induced SE model of TLE is a 
model of SUDEP, 2) pilo-SE mice did not display long-term, chronic abnormal 
heart rhythms or heart rate variability, 3) GABAergic NTS neurons display acute 
(i.e. 1 week post-SE) and long-term (i.e. 6-12 weeks post-SE) hyperexcitability, 4) 
reduced A-type current contributes to hyperexcitability, 5) chemogenetic activation 
of GABAergic NTS neurons alone is not sufficient to induce a seizure or SUDEP, 
but lowers seizure latency in control mice, 6) Activation of an excitatory DREADD 
in GABAergic NTS neurons increases inhibition of preganglionic parasympathetic 
motor neurons. This study is the first to examine the pilocarpine-induced SE model 
of TLE in the context of SUDEP. This study is the first to quantify mortality rates 
from SUDEP in pilo-SE mice. Additionally, these results indicate that GABAergic 
NTS neurons, which modulate parasympathetic output to the periphery are 
functionally altered in TLE mice, potentially contributing to SUDEP.  
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6.2 The Pilo-SE model of TLE as a model of SUDEP 
6.2.1 Survival of Pilo-SE mice 
 Many studies have examined SUDEP in the context of genetic epilepsies, 
with a focus on channelopathies that are associated with seizures. In studies using 
a mouse model of Dravet’s Syndrome, sudden death has ranged from postnatal 
day 16 to postnatal day 150 (Yu et al., 2006; Cheah et al., 2012; Auerbach et al., 
2013; Cheah et al., 2013; Kalume et al., 2013). There does appear to be difference 
in the onset of sudden death occurrences in a global heterozygous Nav1.1 knock-
in model (Yu et al., 2006) versus a cre-driven deletion of Nav1.1 (Cheah et al., 
2012). However, mice with genetic mutations to recapitulate Dravet’s Syndrome 
only have a small number of seizures (e.g. 1-12 seizures total) before dying 
suddenly (Ogiwara et al., 2007; Cheah et al., 2012; Auerbach et al., 2013). By 
comparison, pilo-SE mice have approximately 2 seizures per day beginning at 4-6 
weeks post-SE (Shibley and Smith, 2002; Groticke et al., 2007; Hunt et al., 2013). 
KCNA1-null mice also experience behavioral seizures and SUDEP beginning at 
postnatal day 14-21 (Glasscock et al., 2010), presumably as consequence of the 
deletion of Kv1.1 potassium channels, but no data has been published regarding 
seizure frequency prior to death (Gautier and Glasscock, 2015). 
Not including mice that died 1-7 days post-SE, there is a 23% survival rate 
150 days post-treatment in pilo-SE mice compared to control mice. Mice that died 
within the week following pilocarpine treatment were not considered to have died 
of SUDEP because they did not develop spontaneous seizures. Additionally, mice 
begin to suffer from SUDEP 16 days post-SE, with 60% having died after 6 weeks 
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(Derera et al., 2017). This study is the first to show the mice that develop and 
survive status epilepticus go on to die of SUDEP.  
6.2.2 Cardiac changes in pilo-SE mice 
 Individuals with TLE who are at risk for SUDEP or eventually die from 
SUDEP display cardiac abnormalities such as increased heart rate, depressed 
HRV, and arrhythmias (Mayer et al., 2004; Ronkainen et al., 2005; Suorsa et al., 
2011; Romigi et al., 2016). Mouse models of genetic epilepsy also display cardiac 
abnormalities, such as in Dravet’s syndrome, where mice have increased heart 
rate directly preceding sudden death (Auerbach et al., 2013). KCNA1 knockout 
mice have arrhythmias and autonomic blockade decreases the frequency of 
atrioventricular block, suggesting that a central autonomic change might be 
responsible for these abnormal heart rhythms (Glasscock et al., 2010).  
 This dissertation examined heart rate and heart rate variability at 4 time 
points: 24 hours pre-treatment, 24 hours post-treatment, 6 weeks, and 12 week 
post-treatment in control and pilo-SE mice. While there was a significant increase 
in heart rate and decrease in HRV 24 hours post-treatment in pilo-SE mice, there 
were no significant differences in the later time points when animals should have 
developed spontaneous seizure activity. Previous studies using the pilocarpine-
induced SE model of TLE had examined heart rhythms and autonomic balance 1-
2 weeks post-treatment and used rats instead of mice (Metcalf et al., 2009a; Bealer 
et al., 2010; Bealer et al., 2011). At rest, mice have a significantly higher heart rate 
compared to rats, which may contribute to heart rate differences seen in 
pilocarpine-treated rats compared to mice (Lujan et al., 2012).  Within 30 minutes 
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of SE, there is a significant increase in heart rate in pilocarpine-treated rats 
(Metcalf et al., 2009b). This increase persists 1 and 2 weeks post-SE (Metcalf et 
al., 2009a). This study also concluded that a decrease in vagal tone, leading to a 
dominance in sympathetic drive is responsible for autonomic imbalance and a 
persistent increase in heart rate, increasing the risk for sudden death (Metcalf et 
al., 2009a). Overall, alterations heart rate and HRV occur acutely in pilo-SE mice, 
but more work needs to be done to determine if long-term changes occur as a 
result of chronic spontaneous seizure activity resulting in increased SUDEP risk.  
6.2.3 Future directions 
 While this study shows that pilo-SE mice die from SUDEP, it was unable to 
pinpoint seizures in relation to sudden death or the actual death itself. It would 
have been more impactful to record video-EEG in these animals. This would have 
allowed for the exact time of death to be determined and record if a seizure event 
directly preceded SUDEP. The video component would have been useful in 
determining if there was any altered respiratory function, such as gasping behavior 
after a seizure and/or prior to death.  
 In the future, the addition of video-EEG to the cardiac monitoring would be 
a valuable way to decipher pre-, inter-, and post-ictal periods during a spontaneous 
seizure occurrence. It would allow for more specific examination of cardiac 
rhythms. For example, the use of EEG would allow for the comparison of heart rate 
and HRV between seizure periods instead of during random time points, making 
this study more similar to those examining individuals with epilepsy. This could 
allow for more clear interpretation of autonomic alterations during epileptogenesis 
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as well, because inter-ictal autonomic changes may be more predictive of SUDEP 
risk than changes that occur surrounding a specific seizure event. The addition of 
continuous ECG monitoring instead of only recording at 4 time points would also 
be more informative of cardiac changes. There were 2 animals that were initially 
part of this study that died suddenly just prior to the 8 weeks-post SE, but because 
there was not continuous ECG recording, it was impossible to determine if cardiac 
abnormalities occurred prior to death. Ultimately, these additions could allow for a 
better interpretation of autonomic function over time in association with seizure 
development.  
6.3 Alterations in GABAergic NTS neuron excitability 
6.3.1 Synaptic and intrinsic changes in GABAergic NTS neurons 
 GABAergic NTS neurons receive glutamatergic, or excitatory, input 
primarily from the postsynaptic terminals in the afferent fibers of the vagus nerve 
that terminate at the ST. Previous research shows that GABAergic NTS neurons 
alter their function as a consequence of various pathological states such as 
hypoxia and diabetes (Zsombok and Smith, 2009; Kline, 2010; King et al., 2012; 
Boychuk et al., 2015a). This dissertation examined GABAergic NTS neuron 
function in a mouse model of TLE and SUDEP. While there were no changes in 
the resting membrane potential or input resistance of GABAergic NTS neurons 
following pilocarpine-induced SE, there were significant alterations in the synaptic 
properties of these neurons. One week post-SE these neurons displayed 
significant increases in spontaneous action potential and sEPSC frequency. Even 
more interesting, there appeared to be sustained long-term changes in excitability. 
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This was evidenced by increases in spontaneous action potential, sEPSC, and 
mEPSC frequency 6 and 12 weeks post-SE. Spontaneous and mEPSC frequency 
increases were not accompanied by increases in amplitude, indicative of an 
increase in excitatory neurotransmitter release from presynaptic terminals, such 
as the vagal afferent terminals in the ST. Additionally, when the ionotropic 
glutamate blocker kynurenic acid was applied to slices, there was a significant 
decrease in excitability as indicated by a decrease in sEPSC frequency in 
GABAergic neurons from pilo-SE mice.  
 A significant increase in mEPSC frequency but not amplitude is suggestive 
of an increase in presynaptic release probability of glutamate (i.e. readily 
releasable vesicle pool) or an increase in the number of functional synapses (Kline, 
2008; Pinheiro and Mulle, 2008; Queenan et al., 2012). To test the hypothesis that 
there was a change in either of these properties, paired pulse and frequency-
dependent depression was examined. It has been theorized that this type of 
synaptic plasticity in the NTS serves to prevent excessive alterations to blood 
pressure (Liu et al., 2000; Kline, 2008). While this dissertation is the first to examine 
paired pulse and frequency-dependent depression in GABAergic NTS neurons in 
a mouse model of TLE, there were no significant differences in either of these 
parameters. Therefore, the increase in excitability seen in GABAergic NTS 
neurons from pilo-SE mice is likely not due to an increase in the vesicle pool or an 
increase in synapses stemming from vagal afferent terminals. Local glutamatergic 
neurons within NTS circuitry can also influence GABAergic firing properties 
(Champagnat et al., 1986; Kawai and Senba, 1996). For example, increases in the 
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amount of excitatory neurotransmitter or slow turnover within the synaptic cleft can 
also alter excitability (Chen and Bonham, 2005; Kline, 2008). Additionally, there 
exists multiple subgroups within the NTS neuron population that are dependent on 
the location of vagal afferent fiber terminals. Cardiovascular afferents terminate in 
the lateral and medial NTS, while afferents from the stomach terminate in the 
commissural NTS (Barraco et al., 1992; Babic et al., 2015). Electrophysiology 
recordings of evoked EPSCs in paired pulse and frequency-dependent depression 
studies did not differentiate between these subpopulations. Thus, recordings from 
various NTS subpopulations may have confounded effects of presynaptic 
glutamate release from vagal afferents.  
6.3.2 Future directions 
 To examine vagal afferent firing properties further, future studies should 
focus on GABAergic neurons within the lateral and medial NTS, in order to better 
isolate alterations in synaptic plasticity from cardiovascular afferents. Additional 
work could also be done examining local glutamatergic NTS neurons. 
Immunohistochemical studies labeling vesicular glutamate transporter 2 
(VGLUT2), which is present in the NTS (Hermes et al., 2014; Bach et al., 2015), 
would provide insight into the sites of origin for increased glutamate 
neurotransmitter release. As labeling for VGLUT2 would also presumably label 
vagal afferent terminals, this could allow for differentiation between glutamate 
release in the ST versus local glutamatergic NTS neurons. To more closely 
examine the structural relationship between presynaptic terminals from local 
glutamatergic NTS neurons, VGLUT, and postsynaptic 2nd order GABAergic NTS 
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neurons, electron microscopy could be used. This could provide insight into the 
differences in the number of glutamate vesicles in the presynaptic terminal 
between control and pilo-SE solely in local glutamatergic NTS neurons. The 
relationship between the potential modulation of excitatory neurotransmission onto 
2nd order GABAergic neurons by local glutamatergic NTS neurons has not been 
well-examined, and these future studies would provide insight from both basic 
science and pathological perspectives.  
6.4 Effects of TLE on voltage-gated K+ current in GABAergic NTS neurons 
6.4.1 Reduced IA contributes to hyperexcitability in GABAergic NTS 
neurons from pilo-SE mice 
 IA plays a prominent role in maintaining neuronal excitability by modulating 
action potential repolarization (Mitterdorfer and Bean, 2002; Birnbaum et al., 
2004). IA is present in NTS neurons and has been altered in response to various 
pathological in states (Moak and Kunze, 1993; Bailey et al., 2002; Belugin and 
Mifflin, 2005; Bailey et al., 2007; Accorsi-Mendonca et al., 2015; Strube et al., 
2015). This dissertation examined the effects of 4-AP, an IA blocker, on action 
potential frequency and half-width and also isolated IA in GABAergic NTS neurons. 
GABAergic NTS neurons from pilo-SE mice displayed a decrease in sensitivity to 
4-AP, while in contrast, GABAergic NTS neurons from control animals showed 
significant increases in both action potential frequency and half-width. There was 
also a significant increase in sEPSC frequency upon application of 4-AP. This 
occurs because 4-AP depolarizes pre-synaptic terminals, increasing 
neurotransmitter release, which is similar to what others have seen in the 
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hippocampus and NTS (Buckle and Haas, 1982; Gu et al., 2004; Haji and Ohi, 
2010). Peak transient outward A-type current in GABAergic NTS neurons was 
significantly reduced, with no changes in the kinetics of activation or inactivation in 
pilo-SE mice compared to control mice. The lack of change in activation or 
inactivation kinetics suggests that there is not a change in the voltage-sensing pore 
region of the voltage-gated K+ channels (Birnbaum et al., 2004; Jerng et al., 2004). 
This dissertation was first to examine IA in GABAergic NTS neurons in the 
pilocarpine-induced SE model of TLE. It also shows that TLE can induce long-term 
alterations in a crucial modulator of neuronal excitability.  
6.4.2 Kv4 and KChIP expression in GABAergic NTS Neurons 
 It was hypothesized that the reduction in IA was due to a downregulation in 
the expression of genes that encode the Kv4 family of voltage-gated K+ channels. 
Kv4.1, Kv4.2, and Kv4.3 modulate the A-type current and can therefore affect IA 
amplitude (Birnbaum et al., 2004; Strube et al., 2015). In one study a viral construct 
was transfected into hippocampal cell cultures leading to a downregulation in 
Kv4.2, as evidenced by action potential broadening and frequency increases (Kim 
et al., 2005), similar to the electrophysiological data described in Chapter 4 of this 
dissertation. When qRT-PCR was utilized to test for differences in expression in 
Kv4.1, Kv4.2, and Kv4.3 there were no significant alterations in mRNA expression 
in tissue samples from pilo-SE mice relative to control mice. This in contrast to 
other studies examining the Kv4 subfamily in the hippocampus in TLE rodents, 
which found decreases in Kv4.2 and Kv4.3 protein (Tsaur et al., 1992; Monaghan 
et al., 2008; Su et al., 2008). However, a separate study found there were no 
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changes in IA or Kv4.2 and Kv4.3 in pilocarpine-treated rats that developed 
spontaneous seizure activity (Ruschenschmidt et al., 2006). KChIPs can also 
modify the conductance of Kv4 channels (Beck et al., 2002; Birnbaum et al., 2004; 
Covarrubias et al., 2008), so qRT-PCR was utilized to test for differences in 
expression in KChIP1, KChIP3, and KChIP4. No significant differences were found 
in any of the KChIPs in pilo-SE mice relative to controls. Again, this differs from 
the literature where studies have shown a downregulation in KChIP1 months after 
pilocarpine-induced SE (Monaghan et al., 2008; Su et al., 2008).   
6.4.3 Future directions 
 There are several reasons why there may be a reduction in IA, suggestive 
of increased excitability, without a concomitant decrease in Kv4 or KChIP 
expression. Studies that examined Kv4 and KChIP expression in the hippocampus 
of pilocarpine treated mice did not also examine the electrophysiology of the A-
type current (Tsaur et al., 1992; Monaghan et al., 2008; Su et al., 2008) and 
electrophysiological studies did not also examine gene expression (Bernard et al., 
2004). The 1mm tissue samples that the RNA was isolated from contained the 
majority of the vagal complex, including neurons from NTS, DMV, and area 
postrema (Bach et al., 2015; Boychuk et al., 2015a; Boychuk et al., 2017). 
Although the majority of neurons within the NTS are GABAergic (Chan and 
Sawchenko, 1998), the tissue sampling process used in this dissertation inevitably 
samples from a heterogeneous cell population. An alternative approach to more 
accurately measure Kv4 and KChIP expression includes single cell qRT-PCR 
which would allow for differences in expression to be measured from single 
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GABAergic NTS neurons, identified by GFP. In the hippocampus, it has been 
shown that increased channel phosphorylation via protein kinase C (PKC) in 
neurons from TLE mice is associated with altered A-type current excitability 
(Bernard et al., 2004). Additionally, biochemical studies have shown that site-
directed mutagenesis of phosphorylation sites on Kv4 channels alters the A-type 
current (Nakamura et al., 1997; Schrader et al., 2002). Antibodies have been 
developed for several phosphorylation sites on Kv4.2 (Birnbaum et al., 2004), and 
could be used to examine differences in the amount of phosphorylated channel in 
GABA NTS neurons. Western blotting could also be utilized to determine 
differences in phosphorylated Kv4 channel protein compared to total Kv4 channel 
protein in control and pilo-SE mice. Overall, more work is necessary to determine 
why there is a reduction an IA but no change in RNA expression.  
6.5 Chemogenetic modulation of vagal complex neurons in TLE 
6.5.1 Activation of GABAergic NTS neurons in whole animals 
 The use of DREADDs to modify whole animal behavior has become 
increasingly popular in studies examining feeding, addiction and anxiety (Whissell 
et al., 2016; Roman et al., 2017; Grafe et al., 2018; Ray et al., 2018; Runegaard 
et al., 2018; Zhang et al., 2018). This dissertation used an excitatory DREADD that 
allowed for the activation of GABAergic NTS neurons via CNO to test the 
hypothesis that these neurons were directly involved in seizure activity and 
SUDEP. A study using genetic epilepsy models showed that in anesthetized mice, 
a pharmacologically induced cortical seizure can spread to the caudal brainstem 
resulting in spreading depression and SUDEP (Aiba and Noebels, 2015). This is 
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significant because the caudal brainstem contains the NTS, which is directly 
implicated in SUDEP because of this study. However, until this dissertation, this 
has not been similarly tested in TLE. GABAergic NTS neurons were activated via 
i.p. CNO injection 20 minutes prior to the induction of an acute seizure. None of 
the animals died from SUDEP. Additionally, CNO did not have an effect on seizure 
latency in pilo-SE animals. Interestingly, CNO significantly reduced seizure latency 
in control animals. DREADDs-mediated activation of GABAergic NTS neurons 
from control mice may have had a greater effect on seizure latency compared to 
pilo-SE mice because the control animals never exhibited spontaneous seizures 
prior to flurothyl, so they may be more susceptible to the effect of CNO on seizure 
latency. Whereas GABAergic NTS neurons from pilo-SE mice are already 
hyperexcitable, and therefore CNO may have less of an effect on seizure latency. 
This study also shows that DREADDs are capable of modulating seizure activity 
in control animals.  
This dissertation differed significantly from that of Aiba and Noebels in many 
ways. Aiba and Noebels used mouse genetic epilepsy models to determine if 
brainstem structures were involved in SUDEP. Using both in vivo and in vitro 
techniques, they showed that NTS is particularly susceptible to spreading 
depression, ultimately leading to cardiorespiratory collapse and sudden death 
(Aiba and Noebels, 2015). In their study a chemoconvulsant was applied directly 
to cortical tissue, cortical EEG was measured during this application, and direct 
current was recorded in the caudal brainstem. This dissertation used a different 
seizure induction method and did not record EEG or brainstem current. However, 
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the study by Aiba and Noebels is confounded by their use of genetic epilepsy 
models because their results may be due to genetic mutations instead of the 
seizures (Aiba and Noebels, 2015). Additionally, while these genetic epilepsy 
models have a reduction in Na+ current in regions of the cortex (Yu et al., 2006; 
Cheah et al., 2012; Kalume et al., 2013; Ogiwara et al., 2013), this has not been 
investigated in NTS neurons.  
Interestingly, in the Aiba and Noebels study, when KCl was injected directly 
into the NTS, seizure-like waveforms occurred in the cortex (Aiba and Noebels, 
2015). The NTS does project to and receive projections from higher brainstem 
centers such as the amygdala and hypothalamus (Ricardo and Koh, 1978; van der 
Kooy et al., 1984; Takenaka et al., 1995; Fontes et al., 2001; Affleck et al., 2012). 
Additionally, changes in NTS neuron activation in response to cortical seizure 
activity can occur independently of blood pressure changes, showing that input 
from vagal afferents is not necessary for NTS neuron plasticity to occur (Kanter et 
al., 1995) . One treatment for refractory epilepsy whose mechanism is poorly 
understood but appears to involve these pathways is vagal nerve stimulation 
(VNS). VNS consists of a device that is implanted under the chest skin with a wire 
attached to the vagus nerve delivering electrical pulses to the nerve preventing 
seizures. While successful, it has not been well-established exactly how VNS is 
capable of preventing seizures (Uthman, 2000; Howland, 2014; Giordano et al., 
2017). One study has suggested that electrical activation of the NTS attenuates 
amygdala-kindled seizures (Magdaleno-Madrigal et al., 2002), however specific 
neuronal subtypes were not investigated. This dissertation has shown that NTS 
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neurons experience functional changes in association with epileptogenesis, but 
this area could also be targeted for potential epilepsy treatments in individuals with 
refractory TLE. 
In other epilepsy models, inhibitory DREADDs have been utilized to 
attenuate seizure activity (Avaliani et al., 2016; Wicker and Forcelli, 2016). In one 
study using kindled mice, the dose of CNO that was most effective in reducing 
seizure severity was much greater (2.5, 5, and 10 mg/kg) compared to this study 
(1 mg/kg) (Wicker and Forcelli, 2016). Additionally, Wicker and Forcelli used a 
1mg/kg dose, but it did not significantly suppress seizure severity (Wicker and 
Forcelli, 2016).  
 There are additional concerns regarding the conversion of CNO to 
clozapine (MacLaren et al., 2016; Gomez et al., 2017; Raper et al., 2017; Manvich 
et al., 2018). CNO is the compounds that binds to and activates DREADDs. 
Studies optimizing DREADDs have shown that it is a pharmacologically inert 
metabolite of the antipsychotic compound of the drug clozapine (Armbruster et al., 
2007; Roth, 2016). Additionally, while clozapine does have high affinity for 
DREADDs, CNO is supposed to have a more potent and therefore efficacious 
effect (Armbruster et al., 2007). One caveat to these drug binding studies is that 
they were done in yeast cultures and not whole animal systems. The studies 
asserting that CNO is reverse metabolized to clozapine, binds to DREADDs 
receptors with high affinity, and produces clozapine effects were done using 
rodents, which are typically utilized in chemogenetics (Gomez et al., 2017; 
Manvich et al., 2018). Additionally, one of the studies showed that clozapine 
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crosses the blood brain barrier more effectively then CNO, but the sample sizes 
were extremely small, with 2 rats per group (Gomez et al., 2017). However, a 
separate study concluded that while CNO metabolizes to clozapine, it does so in 
insignificant amounts, and therefore does not have an effect (Guettier et al., 2009). 
In a small cohort of animals that did not contain mCherry-expressing GABAergic 
NTS neurons, there were no off-target effects of CNO in vitro. However, this was 
not tested in the in vivo studies with flurothyl-induced seizures in this dissertation.  
Behavioral and motor testing can be done on mice to ensure that CNO does 
not produce clozapine-like effects. Antipsychotic agents, such as clozapine, can 
cause catalepsy, which is characterized by behavioral immobility and muscle 
rigidity. To determine if CNO administration causes a clozapine-like effect on 
behavior, the open field test can be used to test for behavioral immobility. If 
clozapine-like effects are evident, there should be a decrease in overall movement 
in the open field test and periods of immobility where the animal is stationary. This 
can also be compared to systemic injection of clozapine and vehicle in mice with 
and without DREADDs.   
6.5.2 Activation of GABAergic NTS neurons using in vitro slice 
electrophysiology 
 The hypothesis that CNO was able to activate mCherry-expressing 
GABAergic neurons and also inhibit downstream vagal motor neurons was tested 
in control and pilo-SE mice. CNO application elicited a depolarization in mCherry 
expressing neurons from both control and pilo-SE mice. Interestingly, this effect 
was slightly stronger in pilo-SE mice, where mCherry-expressing neurons were 
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depolarized 2.5% more than neurons from control mice. There was also a 
significant increase in action potential frequency in GABAergic NTS neurons from 
control and pilo-SE mice. CNO-mediated activation of GABAergic NTS neurons 
led to the inhibition of downstream DMV neurons, a portion of which are 
preganglionic parasympathetic neurons. DMV neurons from pilo-SE mice were 
5.62% more inhibited after mCherry-expressing neuron activation than control 
mice. This suggests that GABAergic NTS neurons from pilo-SE mice are 1) more 
susceptible to CNO-induced depolarization and 2) their activation leads to 
increased downstream inhibition of DMV neurons. These data suggest that pilo-
SE mice have an increased propensity for parasympathetic inhibition upon 
activation of GABAergic NTS neurons, which could lead to autonomic balance, one 
of the main risk factors for SUDEP.  
6.5.3 Future directions 
 In the future the in vivo studies should be repeated with higher dose of CNO. 
In a study using kindling to induce epilepsy combined with an inhibitory DREADD 
to silence seizures, a much higher doses of CNO was needed to reduce seizure 
severity compared this dissertation (Wicker and Forcelli, 2016). Additionally, CNO 
was dissolved at a much higher concentration in the aforementioned study 
compared to the in vivo seizure induction in this dissertation (Wicker and Forcelli, 
2016). The dose and concentration of CNO in this dissertation were chosen were 
based on efficacy in previously published studies and to minimize potential 
conversion of CNO to clozapine (Guettier et al., 2009). Perhaps modifying the 
concentration and dosing of CNO would elicit alterations in seizure behavior.  
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 To avoid an effect of the flurothyl treatment, alternative methods similar to 
that of Aiba and Noebels could be used to elicit a seizure (Aiba and Noebels, 
2015). One option would be to apply a chemoconvulsant, such as 4-AP directly to 
cortical tissue and measure brainstem currents. Another option includes 
microinjection of KCl into the brainstem to elicit spreading depression in an 
anesthetized animal after i.p. injection of CNO. In this case it could be determined 
if CNO causes a pilo-SE animal to develop spreading depression more quickly 
than without CNO and compared to control animals in the same conditions. This 
has technique has been used successfully by others to elicit spreading depression 
in both the cortex and brainstem (Aiba and Noebels, 2015; Nasretdinov et al., 
2017).  
6.6 Summary 
 While potential mechanisms of SUDEP have been heavily studied in genetic 
epilepsy models (Glasscock et al., 2010; Cheah et al., 2012; Auerbach et al., 2013; 
Kalume et al., 2013; Aiba and Noebels, 2015), this dissertation is the first to do so 
in a mouse model of TLE, which is a model of acquired epilepsy. This is impactful 
on the field since over 50% of individuals with epilepsy have TLE and over half of 
those are at high risk for SUDEP, compared to the 1-2% of individuals that have 
genetic epilepsies. Genetic epilepsies also tend to be more severe and have more 
comorbidities than those with TLE. This dissertation was the first to show that TLE 
mice die from SUDEP and that functional changes in GABAergic NTS neurons 
occur in response to pilocarpine-induced TLE. These neurons are crucial 
integrators of cardiorespiratory information and modulators of peripheral output of 
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parasympathetic tone, impacting autonomic balance.  This dissertation has shown 
that these neurons develop an increase in excitability, which in part is due to a 
reduction in the A-type K+ current. However, this study did not find that 
chemogenetic activation of GABAergic NTS neurons could directly lead to a 
seizure or SUDEP in this mode. The exact role that these changes play in SUDEP 
in TLE remains to be elucidated and SUDEP in this model is most likely due to a 
combination of factors including alterations in autonomic, cardiac, and respiratory 
systems.  
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